JP3963491B2 - Crystalline maltosyl glucoside, its production method and use - Google Patents
Crystalline maltosyl glucoside, its production method and use Download PDFInfo
- Publication number
- JP3963491B2 JP3963491B2 JP06526195A JP6526195A JP3963491B2 JP 3963491 B2 JP3963491 B2 JP 3963491B2 JP 06526195 A JP06526195 A JP 06526195A JP 6526195 A JP6526195 A JP 6526195A JP 3963491 B2 JP3963491 B2 JP 3963491B2
- Authority
- JP
- Japan
- Prior art keywords
- glucoside
- maltosyl
- starch
- weight
- crystalline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 24
- 150000008131 glucosides Chemical class 0.000 title description 117
- 229930182478 glucoside Natural products 0.000 title description 116
- 239000013078 crystal Substances 0.000 claims description 98
- 238000000034 method Methods 0.000 claims description 79
- 102000004190 Enzymes Human genes 0.000 claims description 76
- 108090000790 Enzymes Proteins 0.000 claims description 76
- 239000000047 product Substances 0.000 claims description 74
- 230000001603 reducing effect Effects 0.000 claims description 69
- 239000000243 solution Substances 0.000 claims description 64
- 229920002472 Starch Polymers 0.000 claims description 55
- 239000008107 starch Substances 0.000 claims description 55
- 235000019698 starch Nutrition 0.000 claims description 55
- 150000001720 carbohydrates Chemical class 0.000 claims description 49
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 35
- 239000008103 glucose Substances 0.000 claims description 34
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 31
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 30
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 29
- 235000014633 carbohydrates Nutrition 0.000 claims description 28
- 239000007788 liquid Substances 0.000 claims description 24
- 229930006000 Sucrose Natural products 0.000 claims description 17
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 17
- 230000036961 partial effect Effects 0.000 claims description 16
- 238000006116 polymerization reaction Methods 0.000 claims description 16
- 239000005720 sucrose Substances 0.000 claims description 16
- 230000002829 reductive effect Effects 0.000 claims description 15
- 108010019077 beta-Amylase Proteins 0.000 claims description 13
- 239000007857 degradation product Substances 0.000 claims description 13
- 235000000346 sugar Nutrition 0.000 claims description 12
- 239000007864 aqueous solution Substances 0.000 claims description 11
- 108700023372 Glycosyltransferases Proteins 0.000 claims description 9
- 102000051366 Glycosyltransferases Human genes 0.000 claims description 9
- 125000000647 trehalose group Chemical group 0.000 claims description 8
- 229920001353 Dextrin Polymers 0.000 claims description 7
- 239000004375 Dextrin Substances 0.000 claims description 7
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 claims description 7
- 235000019425 dextrin Nutrition 0.000 claims description 7
- 238000000634 powder X-ray diffraction Methods 0.000 claims description 7
- 238000012546 transfer Methods 0.000 claims description 6
- 229920000945 Amylopectin Polymers 0.000 claims description 5
- 229920000856 Amylose Polymers 0.000 claims description 5
- 230000009471 action Effects 0.000 claims description 5
- 238000000354 decomposition reaction Methods 0.000 claims description 5
- 229920000858 Cyclodextrin Polymers 0.000 claims description 4
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 4
- 239000003513 alkali Substances 0.000 claims description 2
- CAKGLMPBYAPFCR-UHFFFAOYSA-N alpha-maltosyl alpha-glucoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)O1 CAKGLMPBYAPFCR-UHFFFAOYSA-N 0.000 claims 13
- 108090000604 Hydrolases Proteins 0.000 claims 5
- 150000008494 α-glucosides Chemical class 0.000 claims 3
- 238000012876 topography Methods 0.000 claims 1
- 229940088598 enzyme Drugs 0.000 description 71
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 65
- 229910001868 water Inorganic materials 0.000 description 60
- 239000000843 powder Substances 0.000 description 39
- 239000007787 solid Substances 0.000 description 32
- 230000000694 effects Effects 0.000 description 27
- 239000000203 mixture Substances 0.000 description 26
- 238000006243 chemical reaction Methods 0.000 description 24
- 238000002474 experimental method Methods 0.000 description 23
- 238000002360 preparation method Methods 0.000 description 22
- 235000013305 food Nutrition 0.000 description 21
- 238000010438 heat treatment Methods 0.000 description 19
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 17
- 238000007796 conventional method Methods 0.000 description 17
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 16
- 238000002425 crystallisation Methods 0.000 description 16
- 239000000126 substance Substances 0.000 description 16
- 230000008025 crystallization Effects 0.000 description 15
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 14
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 13
- 235000003599 food sweetener Nutrition 0.000 description 13
- 239000003381 stabilizer Substances 0.000 description 13
- 239000003765 sweetening agent Substances 0.000 description 13
- 235000019640 taste Nutrition 0.000 description 13
- 239000003814 drug Substances 0.000 description 12
- 239000000499 gel Substances 0.000 description 12
- 238000002844 melting Methods 0.000 description 12
- 230000008018 melting Effects 0.000 description 12
- 239000012498 ultrapure water Substances 0.000 description 12
- -1 α-glucosyl saccharide Chemical class 0.000 description 12
- 239000002537 cosmetic Substances 0.000 description 11
- 239000006071 cream Substances 0.000 description 11
- 239000000546 pharmaceutical excipient Substances 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 239000000796 flavoring agent Substances 0.000 description 10
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 10
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 9
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 9
- 230000002378 acidificating effect Effects 0.000 description 9
- 239000003729 cation exchange resin Substances 0.000 description 9
- 238000001035 drying Methods 0.000 description 9
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 9
- 235000021110 pickles Nutrition 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- 239000003826 tablet Substances 0.000 description 9
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 9
- 239000004373 Pullulan Substances 0.000 description 8
- 229920001218 Pullulan Polymers 0.000 description 8
- FTNIPWXXIGNQQF-UHFFFAOYSA-N UNPD130147 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(OC4C(OC(O)C(O)C4O)CO)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O FTNIPWXXIGNQQF-UHFFFAOYSA-N 0.000 description 8
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 8
- 238000004440 column chromatography Methods 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- FJCUPROCOFFUSR-UHFFFAOYSA-N malto-pentaose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 FJCUPROCOFFUSR-UHFFFAOYSA-N 0.000 description 8
- FJCUPROCOFFUSR-GMMZZHHDSA-N maltopentaose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@@H](CO)O2)O)[C@@H](CO)O1 FJCUPROCOFFUSR-GMMZZHHDSA-N 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 230000017074 necrotic cell death Effects 0.000 description 8
- 235000019423 pullulan Nutrition 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- 108090000637 alpha-Amylases Proteins 0.000 description 7
- 239000006072 paste Substances 0.000 description 7
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 6
- 102100022624 Glucoamylase Human genes 0.000 description 6
- 102000006992 Interferon-alpha Human genes 0.000 description 6
- 108010047761 Interferon-alpha Proteins 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 240000007594 Oryza sativa Species 0.000 description 6
- 235000007164 Oryza sativa Nutrition 0.000 description 6
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 6
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 6
- 235000011130 ammonium sulphate Nutrition 0.000 description 6
- 150000008064 anhydrides Chemical class 0.000 description 6
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 6
- 235000013361 beverage Nutrition 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 239000003337 fertilizer Substances 0.000 description 6
- 239000003456 ion exchange resin Substances 0.000 description 6
- 229920003303 ion-exchange polymer Polymers 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 235000009566 rice Nutrition 0.000 description 6
- 241000251468 Actinopterygii Species 0.000 description 5
- 102000008070 Interferon-gamma Human genes 0.000 description 5
- 108010074328 Interferon-gamma Proteins 0.000 description 5
- 241000589180 Rhizobium Species 0.000 description 5
- 244000299461 Theobroma cacao Species 0.000 description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 235000019688 fish Nutrition 0.000 description 5
- 235000013312 flour Nutrition 0.000 description 5
- 235000011194 food seasoning agent Nutrition 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 5
- 235000012907 honey Nutrition 0.000 description 5
- 229960003130 interferon gamma Drugs 0.000 description 5
- 239000004310 lactic acid Substances 0.000 description 5
- 235000014655 lactic acid Nutrition 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 235000014347 soups Nutrition 0.000 description 5
- 235000013311 vegetables Nutrition 0.000 description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 229920002261 Corn starch Polymers 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 108010028688 Isoamylase Proteins 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- 238000000862 absorption spectrum Methods 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 102000004139 alpha-Amylases Human genes 0.000 description 4
- 229940024171 alpha-amylase Drugs 0.000 description 4
- 235000015218 chewing gum Nutrition 0.000 description 4
- 229940112822 chewing gum Drugs 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- 239000008120 corn starch Substances 0.000 description 4
- 208000002925 dental caries Diseases 0.000 description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 235000013372 meat Nutrition 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 235000020357 syrup Nutrition 0.000 description 4
- 239000006188 syrup Substances 0.000 description 4
- 239000000606 toothpaste Substances 0.000 description 4
- 229940034610 toothpaste Drugs 0.000 description 4
- 239000000052 vinegar Substances 0.000 description 4
- 235000021419 vinegar Nutrition 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 240000007154 Coffea arabica Species 0.000 description 3
- 235000005956 Cosmos caudatus Nutrition 0.000 description 3
- 108010025880 Cyclomaltodextrin glucanotransferase Proteins 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 241000589187 Rhizobium sp. Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 235000009470 Theobroma cacao Nutrition 0.000 description 3
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 3
- LUEWUZLMQUOBSB-UHFFFAOYSA-N UNPD55895 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(O)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O LUEWUZLMQUOBSB-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 235000016213 coffee Nutrition 0.000 description 3
- 235000013353 coffee beverage Nutrition 0.000 description 3
- 239000012228 culture supernatant Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 3
- 239000008298 dragée Substances 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 238000006911 enzymatic reaction Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 235000014109 instant soup Nutrition 0.000 description 3
- UYQJCPNSAVWAFU-UHFFFAOYSA-N malto-tetraose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)O1 UYQJCPNSAVWAFU-UHFFFAOYSA-N 0.000 description 3
- LUEWUZLMQUOBSB-OUBHKODOSA-N maltotetraose Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O[C@@H]3[C@@H](O[C@@H](O)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-OUBHKODOSA-N 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 235000013923 monosodium glutamate Nutrition 0.000 description 3
- 230000003204 osmotic effect Effects 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 229920002401 polyacrylamide Polymers 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 235000021067 refined food Nutrition 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000011218 seed culture Methods 0.000 description 3
- 235000020183 skimmed milk Nutrition 0.000 description 3
- 229940073490 sodium glutamate Drugs 0.000 description 3
- 238000001694 spray drying Methods 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 229940013618 stevioside Drugs 0.000 description 3
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 3
- 235000019202 steviosides Nutrition 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- 239000011721 thiamine Substances 0.000 description 3
- 235000019157 thiamine Nutrition 0.000 description 3
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 235000012431 wafers Nutrition 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 239000004606 Fillers/Extenders Substances 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- 239000002211 L-ascorbic acid Substances 0.000 description 2
- 235000000069 L-ascorbic acid Nutrition 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 244000294411 Mirabilis expansa Species 0.000 description 2
- 235000015429 Mirabilis expansa Nutrition 0.000 description 2
- YBHQCJILTOVLHD-YVMONPNESA-N Mirin Chemical compound S1C(N)=NC(=O)\C1=C\C1=CC=C(O)C=C1 YBHQCJILTOVLHD-YVMONPNESA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 235000008452 baby food Nutrition 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 239000004067 bulking agent Substances 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 229960004106 citric acid Drugs 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 235000011950 custard Nutrition 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 230000007515 enzymatic degradation Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229940079322 interferon Drugs 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 235000013536 miso Nutrition 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- 210000003928 nasal cavity Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000011505 plaster Substances 0.000 description 2
- 229920001592 potato starch Polymers 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 235000011962 puddings Nutrition 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
- 235000019204 saccharin Nutrition 0.000 description 2
- 229940081974 saccharin Drugs 0.000 description 2
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 2
- 235000015067 sauces Nutrition 0.000 description 2
- 235000013580 sausages Nutrition 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000002884 skin cream Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000013555 soy sauce Nutrition 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 235000013547 stew Nutrition 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000007940 sugar coated tablet Substances 0.000 description 2
- 238000009495 sugar coating Methods 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- MYKOKMFESWKQRX-UHFFFAOYSA-N 10h-anthracen-9-one;sulfuric acid Chemical compound OS(O)(=O)=O.C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 MYKOKMFESWKQRX-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 241000208140 Acer Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 241000186073 Arthrobacter sp. Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 description 1
- 235000000536 Brassica rapa subsp pekinensis Nutrition 0.000 description 1
- 241000499436 Brassica rapa subsp. pekinensis Species 0.000 description 1
- 241000186146 Brevibacterium Species 0.000 description 1
- 244000191482 Cantharellus cibarius Species 0.000 description 1
- 235000015722 Cantharellus cibarius Nutrition 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 108010071942 Colony-Stimulating Factors Proteins 0.000 description 1
- 102000007644 Colony-Stimulating Factors Human genes 0.000 description 1
- 241000203810 Curtobacterium citreum Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 241000257465 Echinoidea Species 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 241001058146 Erium Species 0.000 description 1
- 102000003951 Erythropoietin Human genes 0.000 description 1
- 108090000394 Erythropoietin Proteins 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 241000230562 Flavobacteriia Species 0.000 description 1
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 1
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 1
- 244000307700 Fragaria vesca Species 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 101000599940 Homo sapiens Interferon gamma Proteins 0.000 description 1
- 229920001612 Hydroxyethyl starch Polymers 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 102000003996 Interferon-beta Human genes 0.000 description 1
- 108090000467 Interferon-beta Proteins 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 102000000588 Interleukin-2 Human genes 0.000 description 1
- 229940124726 Japanese encephalitis vaccine Drugs 0.000 description 1
- 241000191948 Kocuria rosea Species 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090000542 Lymphotoxin-alpha Proteins 0.000 description 1
- 102000004083 Lymphotoxin-alpha Human genes 0.000 description 1
- 108010048043 Macrophage Migration-Inhibitory Factors Proteins 0.000 description 1
- 102100037791 Macrophage migration inhibitory factor Human genes 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 241000191938 Micrococcus luteus Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- GUZBXMVHVQHCTQ-XFSSMLLMSA-N O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O[C@@H]3[C@@H]([C@@H](O)[C@H](O[C@@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)[C@@H](CO)O3)O)[C@@H](CO)O2)O)[C@@H](CO)O1 Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O[C@@H]3[C@@H]([C@@H](O)[C@H](O[C@@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)[C@@H](CO)O3)O)[C@@H](CO)O2)O)[C@@H](CO)O1 GUZBXMVHVQHCTQ-XFSSMLLMSA-N 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102100026367 Pancreatic alpha-amylase Human genes 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 102000003946 Prolactin Human genes 0.000 description 1
- 108010057464 Prolactin Proteins 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 241001125046 Sardina pilchardus Species 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 102100038803 Somatotropin Human genes 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 241000866060 Terrabacter tumescens Species 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 108010074506 Transfer Factor Proteins 0.000 description 1
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- LWZFANDGMFTDAV-BURFUSLBSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-BURFUSLBSA-N 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-UHFFFAOYSA-N alpha-D-glucopyranose Natural products OCC1OC(O)C(O)C(O)C1O WQZGKKKJIJFFOK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-DVKNGEFBSA-N alpha-D-glucose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-DVKNGEFBSA-N 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- BNABBHGYYMZMOA-AHIHXIOASA-N alpha-maltoheptaose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](O[C@H](O[C@@H]3[C@H](O[C@H](O[C@@H]4[C@H](O[C@H](O[C@@H]5[C@H](O[C@H](O[C@@H]6[C@H](O[C@H](O)[C@H](O)[C@H]6O)CO)[C@H](O)[C@H]5O)CO)[C@H](O)[C@H]4O)CO)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O BNABBHGYYMZMOA-AHIHXIOASA-N 0.000 description 1
- OCIBBXPLUVYKCH-QXVNYKTNSA-N alpha-maltohexaose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](O[C@H](O[C@@H]3[C@H](O[C@H](O[C@@H]4[C@H](O[C@H](O[C@@H]5[C@H](O[C@H](O)[C@H](O)[C@H]5O)CO)[C@H](O)[C@H]4O)CO)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O OCIBBXPLUVYKCH-QXVNYKTNSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229960004543 anhydrous citric acid Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 229960000190 bacillus calmette–guérin vaccine Drugs 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000013064 chemical raw material Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000000991 chicken egg Anatomy 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000020186 condensed milk Nutrition 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 235000012495 crackers Nutrition 0.000 description 1
- 235000021549 curry roux Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 description 1
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 235000012489 doughnuts Nutrition 0.000 description 1
- 235000015071 dressings Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 229940105423 erythropoietin Drugs 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 235000013332 fish product Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229940028334 follicle stimulating hormone Drugs 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 102000043557 human IFNG Human genes 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 229940050526 hydroxyethylstarch Drugs 0.000 description 1
- 239000003230 hygroscopic agent Substances 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229960001388 interferon-beta Drugs 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000001155 isoelectric focusing Methods 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- OOYGSFOGFJDDHP-KMCOLRRFSA-N kanamycin A sulfate Chemical compound OS(O)(=O)=O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N OOYGSFOGFJDDHP-KMCOLRRFSA-N 0.000 description 1
- 229960002064 kanamycin sulfate Drugs 0.000 description 1
- 235000008960 ketchup Nutrition 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 239000007934 lip balm Substances 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- DJMVHSOAUQHPSN-UHFFFAOYSA-N malto-hexaose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(OC4C(C(O)C(O)C(CO)O4)O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 DJMVHSOAUQHPSN-UHFFFAOYSA-N 0.000 description 1
- 235000015090 marinades Nutrition 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 229940041323 measles vaccine Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 235000015205 orange juice Nutrition 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 229960005030 other vaccine in atc Drugs 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 235000015108 pies Nutrition 0.000 description 1
- 239000003375 plant hormone Substances 0.000 description 1
- 229960001539 poliomyelitis vaccine Drugs 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
- 235000012029 potato salad Nutrition 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 238000004262 preparative liquid chromatography Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 235000013324 preserved food Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229940097325 prolactin Drugs 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 235000020185 raw untreated milk Nutrition 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 229930188195 rebaudioside Natural products 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000019685 rice crackers Nutrition 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 235000012046 side dish Nutrition 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000020374 simple syrup Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 229950006451 sorbitan laurate Drugs 0.000 description 1
- 235000011067 sorbitan monolaureate Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000006190 sub-lingual tablet Substances 0.000 description 1
- 229940098466 sublingual tablet Drugs 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 229960000814 tetanus toxoid Drugs 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
- 235000019583 umami taste Nutrition 0.000 description 1
- 229960005356 urokinase Drugs 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 239000008371 vanilla flavor Substances 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000012773 waffles Nutrition 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 150000008501 α-D-glucopyranosides Chemical class 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Description
【0001】
【産業上の利用分野】
本発明は、新規結晶糖質とその製造方法並びに用途に関し、詳細には、結晶マルトシルグルコシドとその製造方法並びに用途に関する。
【0002】
【従来の技術】
マルトトリオースは、式:O−α−D−グルコピラノシル−(1→4)−O−α−D−グルコピラノシル−(1→4)−D−グルコピラノースで示される三糖類で、水飴、粉飴などに含まれる甘味糖質として古くから知られている。この糖質は、低甘味を特徴に各種飲料、加工食品、嗜好物などの組成物に利用されている。
【0003】
しかしながら、マルトトリオースは、還元性糖質であるため、飲料、加工食品、嗜好物などに含まれるタンパク質やアミノ酸などと褐変反応し易く、変質、劣化を起こし易い欠点がある。そこで、本発明者等は、この欠点を解消すべく鋭意研究し、先に特願平5−349216号明細書で記載したグルコース重合度3以上の還元性澱粉部分分解物から末端にトレハロース構造を有する非還元性糖質を生成する酵素(本明細書においては、本酵素を単に「非還元性糖質生成酵素」と略称することがある。)を作用させることにより、マルトトリオースから非還元性のマルトシルグルコシドを生成することを見いだした。しかしながら、この非還元性糖質マルトシルグルコシドの粉末は、非晶質で物理的に不安定であって、より安定な結晶の確立が望まれる。
【0004】
一方、マルトシルグルコシド自体については、例えば、フォン・ヴェルナー・フィッシャー(Von Werner Fischer)等が、『ホッペーザイラース・ツァイトシュリフト・フュル・フィジオロジッセ・ヘミー(Hoppe−Seyler’s Zeitshrift fur Physiologishe Chemie)』、第350巻、第1137乃至1147頁(1969年)で報告している微生物菌体から抽出する方法や、シンキチ・コト(Shinkiti Koto)等が、『ブリティン・オブ・ケミカル・ソサイエティー・オブ・ジャパン(Bulletin of Chemical Society of Japan)』、第59巻、第411乃至414頁(1986年)で報告し、またハンス・ピーター・ベッセル(Hans Peter Wessel)等が、『ヘルベティカ・キミカ・アクタ(Helvetica ChimicaActa)』、第74巻、第682乃至695頁(1991年)で報告している化学的合成法などでその調製方法が知られているものの、その結晶については何らの記載もなく、未だ知られていない。
【0005】
【発明が解決しようとする課題】
本発明は、結晶マルトシルグルコシドの確立と結晶マルトシルグルコシドの製造方法並びにその用途を提供しようとするものである。
【0006】
【課題を解決するための手段】
本発明者等は、上記課題を解決するために、鋭意研究を続けてきた。その結果、還元性澱粉部分分解物であるマルトペンタオースに非還元性糖質生成酵素を作用させて、マルトペンタオースを非還元性のマルトテトラオシルグルコシドに変換させ、次いで、これにβ−アミラーゼを作用させて得られるマルトシルグルコシド含有液を塩型強酸性カチオン交換樹脂を用いるカラムクロマトグラフィーにかけ、精製して得られるマルトシルグルコシド高含有液を濃縮し、冷室に保存していたところ、結晶が析出する現象を見いだし、更に、本結晶が結晶マルトシルグルコシドであることを解明して、新規結晶マルトシルグルコシドを確立するとともに、その製造方法並びに用途を確立して本発明を完成した。併せて、結晶マルトシルグルコシドとして、含水結晶と無水結晶の存在を解明し、その製造方法並びに用途を確立して本発明を完成した。
【0007】
結晶マルトシルグルコシドの製造方法としては、本結晶が製造できる方法であればよく、通常、マルトシルグルコシド含有溶液からこれを晶出、採取する。
【0008】
マルトシルグルコシドを製造するには、化学的合成法であってもよいが、一般的には、糖転移酵素又は非還元性糖質生成酵素などを用いる生化学的方法が有利である。
【0009】
糖転移酵素を用いる方法としては、例えば、トレハロースとα−グルコシル糖質とを含有する水溶液に糖転移酵素を作用させて、例えば、マルトシルグルコシド、マルトトリオシルグルコシド、マルトテトラオシルグルコシドなどのα−D−オリゴグルコシルグルコシドを生成させればよく、必要に応じて、これにβ−アミラーゼ又はβ−アミラーゼとともにプルラナーゼ、イソアミラーゼなどの澱粉枝切酵素を作用させて、マルトシルグルコシドの含量を高めることも有利に実施できる。
【0010】
この際、α−グルコシル糖質としては、使用される糖転移酵素によってトレハロースへグルコース残基をα−1,4結合で1個又は2個以上糖転移できる糖質であればよく、例えば、澱粉、糊化澱粉、液化澱粉、可溶性澱粉、アミロース、アミロペクチン、還元性澱粉部分分解物、澱粉糖転移物、シクロデキストリン、デキストリン、マルトオリゴ糖、蔗糖などのα−グルコシル結合を有する糖質から選ばれる1種又は2種以上の糖質が適宜採用される。
【0011】
通常、糖転移酵素がシクロマルトデキストリン・グルカノトランスフェラーゼ(EC 2.4.1.19)、α−アミラーゼ(EC 3.2.1.1)の場合には、例えば、澱粉、糊化澱粉、アミロペクチン、アミロース、還元性澱粉部分分解物、シクロデキストリン、デキストリン、マルトオリゴ糖などが好適であり、また、α−グルコシダーゼの場合には、マルトース、マルトトリオース、マルトテトラオース、マルトペンタオースなどのマルトオリゴ糖、デキストリン、蔗糖などが好適である。
【0012】
また、非還元性糖質生成酵素を用いて、マルトシルグルコシドを生成させるには、高純度マルトトリオースに該酵素を作用させてもよいが、一般的には、グルコース重合度3以上の還元性澱粉部分分解物に非還元性糖質生成酵素を作用させて、末端にトレハロース構造を有する非還元性糖質、例えば、マルトシルグルコシド、マルトトリオシルグルコシド、マルトテトラオシルグルコシドなどのα−D−オリゴグルコシルグルコシドを生成させればよい。この方法も糖転移酵素を利用する場合と同様に、必要に応じて、更にβ−アミラーゼ又はβ−アミラーゼとともに澱粉枝切酵素を作用させて、マルトシルグルコシドの含量を高めることも有利に実施できる。
【0013】
還元性澱粉部分分解物としては、非還元性糖質生成酵素によってマルトシルグルコシドを生成するか、又はマルトシルグルコシド構造を含む糖質を生成しうるものであればよく、一般的には、澱粉、糊化澱粉、液化澱粉、溶性澱粉、アミロペクチン、アミロース、デキストリン、DE1乃至40の還元性澱粉部分分解物、グルコース重合度3以上のマルトオリゴ糖などが有利に利用できる。
【0014】
本発明に用いる非還元性糖質生成酵素としては、例えば、本発明者等が、先に、特願平5−349216号明細書で記載したように、既に茨城県つくば市東1丁目1番3号にある通商産業省工業技術院生命工学工業技術研究所、特許微生物寄託センターに寄託しているリゾビウム・スピーシーズ(Rhizobium sp.)M−11『受託番号、微工研条寄第4130号(FERM BP−4130)』やアルスロバクター・スピーシーズ(Arthrobacter sp.)Q36『受託番号、FERM BP−4316』などの微生物、更には、公知の、例えば、ブレビバクテリウム・ヘロボルム(Brevibacterium helovolum)ATCC11822、フラボバクテリウム・アクアティレ(Flavobacterium aquatile)IFO3772、ミクロコッカス・ルテウス(Micrococcus luteus)IFO3064、ミクロコッカス・ロゼウス(Micrococcus roseus)ATCC186、クルトバクテリウム・シトレウム(Curtobacterium citreum)IFO15231、マイコバクテリウム・スメグマチス(Mycobacterium smegmatis)ATCC19420、テラバクター・ツメスセンス(Terrabacter tumescens)IFO12960などの非還元性糖質生成酵素産生能を有する微生物を栄養培地に培養し、この培養物を採取し、利用することもできるが、必要ならば、公知の方法で適宜精製して利用してもよい。
【0015】
このようにして得られる非還元性糖質生成酵素は、グルコース重合度3以上から選ばれる1種又は2種以上の還元性澱粉部分分解物から末端にトレハロース構造を有する非還元性糖質を生成する作用を有する。
【0016】
これらの酵素反応条件は、目的の酵素反応が進む限り採用することができるが、一般的には、基質濃度約1乃至50w/w%(以下、本明細書では、特にことわらない限り、w/w%を%で示す。)、反応温度約20乃至80℃、反応pHは、約4乃至10、反応時間は、約1乃至100時間から選ばれる条件から採用される。これら反応に利用される酵素は、必要に応じて、担体結合法、架橋法、包括法などの公知方法により固定化して、連続反応に利用することも、回分反応で繰り返し利用することも随意である。
【0017】
以上述べたような酵素反応には、通常、固形物当たりマルトシルグルコシドを1乃至67%程度含有している。この反応液から結晶マルトシルグルコシドを製造するには、一般的には、夾雑物質を分離、精製して、マルトシルグルコシド高含有液とし、これを濃縮し、晶出せしめた結晶マルトシルグルコシドを採取するのが有利である。
【0018】
その分離、精製方法としては、例えば、酵母発酵法、膜濾過法、分別沈澱法、アルカリ処理法、クロマトグラフィー法などが適宜採用できる。とりわけ、特開昭58−23799号公報、特開昭59−148794号公報などに開示されている塩型強酸性カチオン交換樹脂を用いるカラムクロマトグラフィーにより、夾雑糖質を除去してマルトシルグルコシド高含有液を採取する方法が有利に実施できる。この際、公知の固定床方式、移動床方式、擬似移動床方式のいずれの方法を採用することも随意である。
【0019】
このようにして得られたマルトシルグルコシド高含有溶液からマルトシルグルコシドを晶出させるには、結晶の種類によって、それぞれ適当な条件が選ばれる。晶出条件としては、マルトシルグルコシドの過飽和溶液であって、結晶マルトシルグルコシドが析出すればよく、マルトシルグルコシド自体の製造方法は問わない。
【0020】
具体的に述べれば、純度60%以上のマルトシルグルコシドを、濃度約65乃至95%又はこれ以上の濃度とし、その溶液の温度は、溶液が凍結せず、また結晶の融点以下でマルトシルグルコシドの褐変、分解の懸念の少ない温度、例えば、含水結晶の場合、水分約10%以上の溶液を約10乃至90℃で、無水結晶の場合、水分約10%未満の溶液を約90乃至150℃で晶出させればよい。また、無水結晶は、含水結晶を減圧乾燥又は加熱乾燥することによっても容易に製造することができる。また、晶出させるに際して、溶液の過飽和度、粘度などを調整するために、例えば、メタノール、エタノール、アセトンなどを共存させることも随意である。
【0021】
晶出方法は、通常、比較的高温の過飽和マルトシルグルコシド含有溶液を助晶缶にとり、これに種晶を、望ましくは、0.1乃至20%共存せしめて、ゆっくり攪拌しつつ、徐冷し、晶出を促してマスキットにすればよい。
【0022】
晶出したマスキットから結晶マルトシルグルコシドを製造する方法は、結晶マルトシルグルコシドが採取できればよく、例えば、分蜜方法、ブロック粉砕方法、流動造粒方法、噴霧乾燥方法などの公知の方法を利用すればよい。
【0023】
例えば、分蜜方法は、通常、バスケット型遠心分離機にかけ、結晶マルトシルグルコシドと蜜とを分離する方法で、必要により、該結晶に少量の冷水をスプレーして洗浄することも容易であり、より高純度の結晶マルトシルグルコシドを製造するのに好適である。他の三つの方法は、蜜を分離しないので、得られる結晶製品に純度の向上は見られないものの製品収量の多い特長を有している。したがって、本製品の場合には、通常、結晶製品に、マルトシルグルコシド以外に原料又は製造工程由来の糖質、例えば、トレハロース、グルコース、マルトース、マルトトリオース、マルトテトラオースなどの澱粉糖が含まれる。
【0024】
噴霧乾燥方法の場合には、通常、晶出率約25乃至60%のマスキットを高圧ポンプでノズルから噴霧し、結晶粉末が溶融しない温度、例えば、約60乃至100℃の熱風で乾燥し、次いで、温風で乾燥熟成すれば、非吸湿性又は難吸湿性の結晶含有粉末が容易に製造できる。
【0025】
また、ブロック粉砕方法は、通常、晶出率約10乃至60%のマスキットを約0.5乃至5日間静置して全体をブロック状に晶出固化させ、これを粉砕又は切削などの方法によって破砕し、乾燥すれば、非吸湿性、難吸湿性の結晶含有粉末が容易に製造できる。
【0026】
また、マルトシルグルコシド含有水溶液を、常法に従い、水分5%未満に加熱濃縮して、溶融状態とした過飽和マルトシルグルコシド含有溶液とし、この溶液に種晶を結晶の融点以下の温度で混捏し、これを各種形状、例えば、粉体、顆粒、棒状、板状、立方体などに成形して、非吸湿性又は難吸湿性の結晶含有固体を製造することも随意である。
【0027】
このようにして得られる結晶マルトシルグルコシドは、そのマルトシルグルコシドの純度によって、その非吸湿性は多少変動するが、実質的に非吸湿性であり、流動性であり、粘着、固着の懸念も少なく取扱い容易であり、その包装、輸送、貯蔵などの管理に要する物的、人的経費が大幅に削減できる。
【0028】
また、本発明の結晶マルトシルグルコシドは、実質的に非吸湿性乃至難吸湿性の粉末で、耐熱性が高く、安定性もよいので、従来、極めて困難とされていた粉末混合甘味料、チョコレート、チューインガム、即席ジュース、即席スープ、顆粒、錠剤などの賦形剤、増量剤、粉末基剤などとして、例えば、飲食物、化粧品、医薬品、成形物などの各種組成物、更には試薬、化学工業用原料などの各種用途に有利に利用できる。
【0029】
また、結晶マルトシルグルコシドは、その純度の違いにより、融点、比旋光度などの理化学的性質が変化する。このうち融点は、マルトシルグルコシドの純度が低下するにともなって低下し、融点の幅も広くなる。例えば、純度88.6%の結晶マルトシルグルコシドの融点は、138乃至146℃である。したがって、結晶マルトシルグルコシドは、必要性に応じて、その純度を適宜選択して利用すればよい。
【0030】
また、本発明の結晶マルトシルグルコシドは、水に溶け、良質で中程度の甘味を有している。また、経口摂取により、消化吸収され、カロリー源として利用される。更に、虫歯誘発菌などによって、発酵されにくいことより、虫歯を起こしにくい甘味料としても利用できる。また、良質な甘味料、賦形剤であることより、プルラン、ヒドロキシエチルスターチなどの結合剤と併用して、錠剤の糖衣剤として利用することも有利に実施できる。その他、ボディー付与性、照り付与性、保湿性、粘性、耐熱性、耐酸性、非還元性乃至低還元性などの性質を具備している。
【0031】
結晶マルトシルグルコシドの持つこれら諸性質は、食品、嗜好物、飼料、餌料などの飲食物、更には、化粧品、医薬品、成形物など各種組成物の製造に有利に利用できる。
【0032】
本発明の結晶マルトシルグルコシドは、そのままで甘味付けのための調味料として使用することができる。必要ならば、例えば、粉飴、ブドウ糖、マルトース、蔗糖、異性化糖、蜂蜜、メープルシュガー、ソルビトール、ジヒドロカルコン、ステビオシド、α−グリコシルステビオシド、レバウディオシド、グリチルリチン、L−アスパルチル−L−フェニルアラニンメチルエステル、サッカリン、グリシン、アラニンなどのような他の甘味料の1種又は2種以上の適量と混合して使用してもよく、また必要ならば、デキストリン、澱粉、乳糖などのような増量剤と混合して使用することもできる。
【0033】
また、結晶マルトシルグルコシド粉末品は、実質的に難吸湿性の粉末で、耐熱性が大きく、安定性も良いので、増量剤、賦形剤、粉末基剤なとどとして、そのままで、又は必要に応じて、他の増量剤、賦形剤、結合剤などと混合して、顆粒、球状、短棒状、板状、立方体、錠剤など各種形状に成形して使用することも随意である。また、本粉末品は、小麦粉、コーングリッツ、澱粉などの粉類の一部に置き換えて、例えば、製菓材料、製パン材料、シリアル材料などに利用することも有利に実施できる。
【0034】
また、結晶マルトシルグルコシドの甘味は、酸味、塩から味、渋味、旨味、苦味などの他の呈味を有する各種物質とよく調和し、耐酸性、耐熱性も大きいので、一般の飲食物の甘味付け、呈味改良に、また品質改良などに有利に利用できる。例えば、醤油、粉末醤油、味噌、粉末味噌、もろみ、ひしお、ふりかけ、マヨネーズ、ドレッシング、食酢、三杯酢、粉末すし酢、中華の素、天つゆ、麺つゆ、ソース、ケチャップ、焼肉のタレ、カレールウ、シチューの素、スープの素、ダシの素、複合調味料、みりん、新みりん、テーブルシュガー、コーヒーシュガーなど各種調味料として有利に使用できる。さらに、例えば、せんべい、あられ、おこし、餅類、まんじゅう、ういろう、あん類、羊羮、水羊羮、錦玉、ゼリー、カステラ、飴玉などの各種和菓子、パン、ビスケット、クラッカー、クッキー、パイ、プリン、バタークリーム、カスタードクリーム、シュークリーム、ワッフル、スポンジケーキ、ドーナツ、チョコレート、チューインガム、キャラメル、キャンデーなどの各種洋菓子、アイスクリーム、シャーベットなどの氷菓、果実のシロップ漬、氷蜜などのシロップ類、フラワーペースト、ピーナッツペースト、フルーツペースト、スプレッドなどのペースト類、ジャム、マーマレード、シロップ漬、糖果などの果実、野菜の加工食品類、福神漬、べったら漬、千枚漬、らっきょう漬などの漬物類、たくあん漬の素、白菜漬の素などの漬物の素類、ハム、ソーセージなどの畜肉製品類、魚肉ハム、魚肉ソーセージ、かまぼこ、ちくわ、天ぷらなどの魚肉製品、ウニ、イカの塩辛、酢コンブ、さきするめ、ふぐみりん干しなどの各種珍味類、のり、山菜、するめ、小魚、貝などで製造されるつくだ煮類、煮豆、ポテトサラダ、こんぶ巻などのそう菜食品、乳製品、魚肉、畜肉、果実、野菜のビン詰、缶詰類、合成酒、洋酒などの酒類、コーヒー、ココア、ジュース、炭酸飲料、乳酸飲料、乳酸菌飲料などの清涼飲料水、プリンミックス、ホットケーキミックス、即席しるこ、即席スープなどの即席食品、更には、離乳食、治療食、ドリンク剤などの各種飲食物への甘味付けに、呈味改良に、また、品質改良などに有利に利用できる。
【0035】
また、家畜、家禽、その他蜂、蚕、魚などの飼育動物のために飼料、餌料などの嗜好性を向上させる目的で使用することもできる。その他、タバコ、練歯磨、口紅、リップクリーム、内服薬、トローチ、錠剤、肝油ドロップ、口中清涼剤、口中香剤、うがい薬など各種固形状、ペースト状、液状などで嗜好物、化粧品、医薬品などの口中使用物への甘味剤として、又は呈味改良剤、矯味剤として、更には品質改良剤として有利に利用できる。
【0036】
また、結晶マルトシルグルコシドは、例えば、石鹸、スキンクリーム、ボディシャンプー、ヘアクリーム、リップクリーム、美肌剤、育毛剤などへの安定剤、浸透圧調節剤、賦形剤、保湿調節剤、粘度調節剤、品質改良剤などとして化粧品製造に有利に利用できる。
【0037】
更に、生理活性物質、例えば、インターフェロン−α、インターフェロン−β、インターフェロン−γ、ツモア・ネクロシス・ファクター−α、ツモア・ネクロシス・ファクター−β、リンホトキシン、マクロファージ遊走阻止因子、コロニー刺激因子、トランスファー・ファクター、インターロイキン2などのサイトカイン、インシュリン、成長ホルモン、プロラクチン、エリトロポエチン、卵胞刺激ホルモンなどのホルモン、BCGワクチン、日本脳炎ワクチン、はしかワクチン、ポリオ生ワクチン、痘苗、破傷風菌トキソイド、ハブ抗毒素、ヒト免疫グロブリンなどのワクチン、ペニシリン、エリスロマイシン、クロラムフェニコール、テトラサイクリン、ストレプトマイシン、硫酸カナマイシンなどの抗生物質、チアミン、リボフラビン、L−アスコルビン酸、肝油、カロチノイド、エルゴステロール、トコフェロールなどのビタミン、リパーゼ、エステラーゼ、ウロキナーゼ、プロテアーゼ、グルカナーゼなどの酵素、薬用人参エキス、スッポンエキス、クロレラエキス、プロポリス、ローヤルゼリーなどのエキス類、ウイルス、乳酸菌、ビフィズス菌、酵母などの生菌類などの有効成分、活性の安定剤として、更には、浸透圧調節剤、賦形剤、経管栄養剤、シロップ剤などとして医薬品製造に有利に利用できる。以上述べたような飲食物、化粧品、医薬品、成形物など各種組成物に本発明の結晶マルトシルグルコシドを含有せしめる方法は、その組成物が完成するまでの工程に含有せしめればよく、例えば、混和、混捏、溶解、融解、浸漬、浸透、散布、塗布、被覆、噴霧、注入、固化、晶出など公知の方法が適宜選ばれる。その含有せしめる量は、組成物によっても異なるが、一般的には、結晶マルトシルグルコシドとして、0.1%以上、望ましくは0.5%以上の量が好適である。このようにして得られる組成物は、経口的又は非経口的に利用される飲食物、化粧品、医薬品、成形物のみならず、それ以外にも、例えば、生活用品、農林水産用品、化学工業用品など広範な用途を有する。
【0038】
次に、実験により本発明を更に詳細に説明する。
【0039】
まず、実験Aで、非還元性糖質生成酵素の一例として、リゾビウム・スピーシーズ M−11からの酵素の生産、精製及び性質について説明し、その後、該酵素を用いた還元性澱粉部分分解物から末端にトレハロース構造を有する非還元性糖質及びトレハロースの調製例について説明する。次に、実験Bで、本発明の結晶マルトシルグルコシドの調製例とその理化学的性質について述べる。
【0040】
【実験A−1 リゾビウム・スピーシーズ M−11からの非還元性糖質生成酵素の生産】
マルトース2.0w/v%、ペプトン0.5w/v%、酵母エキス0.1w/v%、リン酸二ナトリウム0.1w/v%、リン酸一カリウム0.1w/v%及び水からなる液体培地をpH7.0に調整した。500ml容三角フラスコにこの培地を約100mlずつ入れ、オートクレーブで120℃で20分間滅菌し、冷却して、リゾビウム・スピーシーズ M−11(FERM BP−4130)を接種し、27℃、130rpmで24時間培養したものを種培養液とした。
【0041】
容量30lのファーメンターに種培養の場合と同組成の培地約20lを入れて滅菌、冷却して温度30℃とした後、種培養液1v/v%を接種し、温度30℃、pH6.0乃至8.0に保ちつつ、約24時間通気撹拌培養した。培養液の本酵素活性は約1.5単位/mlであった。培養液の一部を採り遠心分離して菌体と培養液上清とに分離し、更に菌体を50mMリン酸緩衝液(pH7.0)で元の培養液と同じ液量の懸濁液とした後、菌体懸濁液と培養液上清の酵素活性を測定したところ、菌体懸濁液には約0.6単位/mlの酵素活性が、また、培養液上清には約0.9単位/mlの酵素活性が認められた。
【0042】
非還元性糖質精製酵素の活性測定方法は、基質としてマルトペンタオース1.25w/v%(50mMリン酸緩衝液、pH7.0)4mlに酵素液を1ml加え40℃で60分間反応させた後、100℃で10分間加熱して反応を停止させ、その反応液を正確に脱イオン水で10倍に希釈し、その希釈液の還元力をソモギー・ネルソン法にて測定する。対照として、あらかじめ100℃で10分間加熱させることにより失活させた酵素液を用いて同様に測定する。上記の測定方法を用いて、1分間に1μmoleのマルトペンタオースに相当する還元力を減少させる酵素量を1単位と定義した。
【0043】
【実験A−2 酵素の精製】
実験A−1で得られた培養液約18lを超高圧菌体破砕装置ミニラボ(大日本製薬株式会社製)で処理し、含まれる菌体を破砕した。処理液を遠心分離(10,000rpm、30分間)することにより、約16lの上清を得た。その液に飽和度0.2になるように硫安を溶解させ、4℃、1時間放置した後、遠心分離(10,000rpm、30分間)することにより上清を回収した。
【0044】
更に、その液に飽和度0.6になるように硫安を溶解させ、4℃、24時間放置した後、遠心分離(10,000rpm、30分間)して硫安塩析物を回収した。得られた硫安塩析物を10mMリン酸緩衝液(pH7.0)に溶解させた後、同じ緩衝液に対して24時間透析し、遠心分離(10,000rpm、30分間)して不溶物を除いた。その透析液(360ml)を2回に分けて、DEAE−トヨパールゲル(東ソー株式会社製造)を用いたイオン交換カラムクロマトグラフィー(ゲル量300ml)を行った。
【0045】
本酵素はDEAE−トヨパールゲルに吸着し、食塩を含む同緩衝液でカラムから溶出した。得られる酵素活性画分を、2M硫安を含む同緩衝液に対して透析し、その透析液を遠心分離(10,000rpm、30分間)して不溶物を除き、得られる上清をブチルトヨパール650ゲル(東ソー株式会社製造)を用いた疎水カラムクロマトグラフィー(ゲル量300ml)を行った。吸着した本酵素を硫安2Mから0Mのリニアグラジエントによりカラムから溶出させ、酵素活性画分を回収した。続いて、トヨパールHW−55樹脂(東ソー株式会社製造)を用いたゲル濾過クロマトグラフィー(ゲル量300ml)を行い、酵素活性画分を回収した。精製の各工程における酵素活性量、比活性、収率を表1に示す。
【0046】
【表1】
【0047】
表1の工程でゲル濾過溶出液として得られた精製酵素標品をポリアクリルアミドゲル(ゲル濃度7.5w/v%)を用いる電気泳動法で純度を検定したところ、蛋白バンドは単一であることが示され、得られた酵素標品は電気泳動的に単一な純度の高い標品であった。
【0048】
【実験A−3 酵素の性質】
実験A−2で得られた精製酵素標品をSDS−ポリアクリルアミドゲル(ゲル濃度10w/v%)を用いる電気泳動法に供し、同時に泳動した分子量マーカー(日本バイオ・ラド・ラボラトリーズ株式会社製)と比較して本酵素の分子量を測定したところ、分子量約77,000乃至87,000ダルトンであった。
【0049】
精製酵素標品をポリアクリルアミドゲル(2w/v%アンフォライン含有、スウエーデン国、ファルマシア・エルケイビー社製)を用いる等電点電気泳動法に供し、泳動後、ゲルのpHを測定して本酵素の等電点を求めたところ、等電点は約3.6乃至4.6であった。
【0050】
本酵素活性に対する温度の影響、pHの影響は活性測定方法に準じて調べた。結果を図1(温度の影響)、図2(pHの影響)に示した。酵素の至適温度は、pH7.0、60分間反応で、40℃付近、至適pHは、40℃、60分間反応で、約7.0であった。本酵素の温度安定性は、酵素溶液(50mMリン酸緩衝液を含む、pH7.0)を各温度に60分間保持し、水冷した後、残存する酵素活性を測定することにより求めた。また、pH安定性は、本酵素を各pHの50mM緩衝液中で25℃、16時間保持した後、pHを7に調整し、残存する酵素活性を測定することにより求めた。それぞれの結果を図3(温度安定性)、図4(pH安定性)に示した。本酵素の温度安定性は40℃付近まで安定であり、pH安定性は約6乃至9であった。
【0051】
【実験A−4 非還元性糖質の調製】
基質として、グルコース、マルトース、マルトトリオース、マルトテトラオース、マルトペンタオース、マルトヘキサオース、又はマルトヘプタオースの20%水溶液を調製し、それぞれに実験A−2で得られた精製酵素標品を基質固形物グラム当たり2単位の割合で加え、40℃、pH7.0で48時間作用させた後、脱塩し、ワコービーズ WB−T−330カラム(和光純薬工業株式会社製)を用いた高速液体クロマトグラフィーで反応生成物を分析した。高速液体クロマトグラフィーは、室温下で行い、溶離液として水を流速0.5ml/分で流し、示差屈折計RI−8012(東ソー株式会社製造)で分析した。その結果を表2に示す。
【0052】
【表2】
【0053】
表2の結果から明らかなように、反応物中には残存するそれぞれの基質と新たに生成したそれぞれの糖質PI、PII、PIII、PIV、PVからなり、それ以外の糖質はほとんど検出されない。それぞれの生成率はグルコース重合度3のPIが比較的低いものの、グルコース重合度4以上のPII、PIII、PIV、PVは85%以上の高い生成率であることが判明した。なお、グルコース、マルトースからは、新たな糖質を生成しないことが判明した。
【0054】
それぞれの反応物から新たに生成した糖質を精製するため、脱色、脱塩、濃縮後、アルカリ金属型強酸性カチオン交換樹脂(XT−1016、Na+型、架橋度4%、東京有機化学工業株式会社製造)を用いたカラム分画を行った。樹脂を内径2.0cm、長さ1mのジャケット付きステンレス製カラム3本に充填し、直列につなぎ、カラム内温度を55℃に維持しつつ、反応糖液を樹脂に対して5v/v%加え、これに55℃の温水をSV0.13で流して分画し、新たに生成した糖質含量97%以上の高純度画分を採取した。得られた高純度画分を真空乾燥し、それぞれ高純度糖質標品を調製した。基質原料に対する収率は、固形物換算で、それぞれPIで約9%、PIIで約65%、PIIIで約82%、PIVで約80%、PVで約77%であった。その純度は、それぞれPIで97.5%、PIIで98.6%、PIIIで99.5%、PIVで98.4%、PVで98.4%であった。
【0055】
またこれらの新たに生成した高純度糖質標品の還元力をソモギー・ネルソン法で測定し、DEで表した。結果は表3にまとめた。
【0056】
【表3】
【0057】
表3の結果から明らかなように、いずれの標品にも僅かな還元力しか認めらなかった。その僅かな還元力は、その標品中に微量に混入、残存している基質由来の還元性マルトオリゴ糖に起因するものと推定され、新たに生成した糖質はいずれも実質的に非還元性であると判断される。
【0058】
【実験A−5 グルコアミラーゼによる酵素分解】
実験A−4において調製した非還元性糖質標品、PI、PII、PIII、PIV又は、PVのそれぞれ50mgを、50mM酢酸緩衝液(pH4.5)1mlに溶解し、1単位のグルコアミラーゼ(生化学工業株式会社製造)を加え、40℃で6時間保ち、酵素分解した後、高速液体クロマトグラフィーで分解物を分析したところ、いずれの標品からも分解物としてグルコースとトレハロースのみが検出された。検出されたグルコース含量、トレハロース含量、その組成モル比の結果を表4に示す。
【0059】
【表4】
【0060】
表4の結果から明らかなように、グルコアミラーゼにより、非還元性糖質PIはグルコース1分子とトレハロース1分子に分解され、非還元性糖質PIIはグルコース2分子とトレハロース1分子に分解され、非還元性糖質PIIIはグルコース3分子とトレハロース1分子に分解され、非還元性糖質PIVはグルコース4分子とトレハロース1分子に分解され、非還元性糖質PVはグルコース5分子とトレハロース1分子に分解されることが判明した。
【0061】
また、グルコアミラーゼの反応特性を考慮すると、これら非還元性糖質の構造はトレハロース分子にグルコース分子がα−1,4結合、もしくはα−1,6結合で結合した糖質で、それぞれ、PIはトレハロース1分子にグルコース1分子が結合したグルコース重合度3の非還元性糖質で、PIIはトレハロース1分子にグルコース2分子が結合したグルコース重合度4の非還元性糖質で、PIIIはトレハロース1分子にグルコース3分子が結合したグルコース重合度5の非還元性糖質で、PIVはトレハロース1分子にグルコース4分子が結合したグルコース重合度6の非還元性糖質で、PVはトレハロース1分子にグルコース5分子が結合したグルコース重合度7の非還元性糖質であると判断される。なお、同様に、非還元性糖質標品、PI、PII、PIII、PIV、又はPVにβ−アミラーゼを作用させたところ、非還元性糖質PI、PIIは分解されず、PIIIはマルトースの1分子とPIの1分子に分解され、PIVはマルトースの1分子とPIIの1分子に分解され、PVはマルトースの2分子とPIの1分子に分解されることが判明した。
【0062】
以上の結果から、本発明の非還元性糖質生成酵素による反応は、基質の低分子化及び高分子化を伴わない、換言すれば、グルコース重合度の変化を伴わない、分子内変換反応と判断され、また、この非還元性糖質生成酵素によって生成した非還元性糖質、PI、PII、PIII、PIV及びPVは、それぞれ、α−グルコシルトレハロース(別名、α−マルトシルグルコシド)、α−マルトシルトレハロース(別名、α−マルトトリオシルグルコシド)、α−マルトトリオシルトレハロース(別名、α−マルトテトラオシルグルコシド)、α−マルトテトラオシルトレハロース(別名、α−マルトペンタオシルグルコシド)及びα−マルトペンタオシルトレハロース(別名、α−マルトヘキサオシルグルコシド)で示されるα−グリコシルトレハロース(Gn−T:但し、Gはグルコース残基を意味し、nは1以上の整数を意味し、Tはα,α−トレハロースを意味する。)であると判断される。
【0063】
【実験A−6 末端にトレハロース構造を有する非還元性糖質とトレハロースの調製】
澱粉部分分解物(松谷化学工業株式会社製造、商品名パインデックス#4)40重量部を水60重量部に加熱溶解し、この溶液を45℃、pH6.5に調整した後、実験A−2の方法で調製した非還元性糖質生成酵素を還元性澱粉部分分解物g当たり1単位の割合になるように加えて96時間反応させ、末端にトレハロース構造を有する非還元性糖質を生成させ、次いで100℃で10分間加熱して、酵素を失活させた。本反応液を濃度約20%まで希釈し、グルコアミラーゼ(ナガセ生化学工業株式会社製造、商品名グルコチーム)を澱粉部分分解物g当たり10単位加えて40時間反応させ、次いで加熱して、酵素を失活させた。本溶液を、常法にしたがって、活性炭にて脱色し、イオン交換樹脂にて脱塩し、濃度約60%に濃縮した。本糖液中には固形物当たり29.5%のトレハロースを含有していた。この濃縮液を塩型強酸性カチオン交換樹脂(オルガノ株式会社販売、商品名CG6000、Na型)が充填されたジャケット付きステンレス製カラムに、60℃、SV 0.4でチャージし、トレハロース高含有画分を採取した。本高含有液は、固形物当たり約90%のトレハロースを含有していた。本溶液を濃度約75%に濃縮した後、助晶缶にとり、種晶としてトレハロース含水結晶を約2%加えて徐冷し、晶出率約45%のマスキットを得た。本マスキットを乾燥塔上のノズルより150kg/cm2の高圧にて噴霧した。これと同時に85℃の熱風を乾燥塔の上部より送風し、底部に設けた移送金網コンベア上に結晶粉末を補集し、コンベアの下より45℃の温風を送りつつ、該粉末を乾燥塔外に徐々に移動させて、取り出した。この結晶粉末を熟成塔に充填して温風を送りつつ、10時間熟成させ、結晶化と乾燥を完了し、トレハロース含水結晶粉末を得た。
【0064】
【実験B−1 マルトシルグルコシドの調製】
純度98%のマルトペンタオース(株式会社林原生物化学研究所製造)5重量部を水10重量部に加熱溶解し、pH7.0、温度40℃に調整し、これに実験A−2の方法で調製した非還元性糖質生成酵素をマルトペンタオースグラム当たり2単位になるように加えた。48時間反応させた後、100℃で20分間加熱して、酵素を失活させた。本溶液中には、マルトテトラオシルグルコシドを固形物当たり約88%含有していた。
【0065】
このマルトテトラオシルグルコシド含有溶液を、pH5.5、温度40℃に調整し、β−アミラーゼ(ナガセ生化学工業株式会社製造、商品名#1500)を固形物グラム当たり20単位になるように加えて、24時間反応させた後、100℃で20分間加熱して、酵素を失活させた。本液には、マルトシルグルコシドを固形物当たり約53%含有しており、その他に、マルトース、マルトトリオースが含まれていた。
【0066】
本液は、常法にしたがって、活性炭にて脱色し、イオン交換樹脂(H型及びOH型)にて脱塩し、固形物濃度約50%に濃縮した。次いで、この濃縮液を、実験A−6の方法に準じて、塩型強酸性カチオン交換樹脂を用いるカラムクロマトグラフィーにかけてマルトシルグルコシド高含有画分を採取した。本液は、固形物当たり約81%のマルトシルグルコシドを含有していた。
【0067】
更に、純度を高めるために、この溶液に、水酸化ナトリウムを0.1Nとなるように加え、100℃で2時間加熱し、還元性糖質を分解した。この反応液は、常法にしたがって、脱色、脱塩し、固形物濃度約50%に濃縮した。本液は、固形物当たり約94%のマルトシルグルコシドを含有していた。採取されたマルトシルグルコシド高含有液を、更にオクタデシルシリカゲルを担体とした分取用液体クロマトグラフィー(株式会社YMC製造、分取用カラムYMC−Pack R−355−15)にかけ、マルトシルグルコシド純度約99%以上の高含有画分を採取した。
【0068】
この画分を常法にしたがって、更に精製し、濃度78%に濃縮し、ビーカーに入れ、4℃の冷室に放置したところ、結晶の析出が認められた。本結晶を遠心分離して集め、少量の水で洗浄し、純度99.9%の含水結晶を得た。また、本品を100℃で一夜減圧乾燥して、無水結晶を得た。
【0069】
これら結晶の理化学的性質を調べたところ、次の通りであった。
(1)元素分析(無水物として)
含水結晶 C=42.4% H=6.8%
無水結晶 C=42.6% H=6.7%
理論値 C=42.86% H=6.39%
(2)質量分析(無水物として)
MW=504(分子式C18H32016)
(3)水分
カールフィッシャー法にて測定
含水結晶 9.9%(マルトシルグルコシド1モルに水3モル)
無水結晶 0.3%
(4)融点
マルトシルグルコシドの含水結晶又は無水結晶を融点測定器に入れ、昇温速度を毎分1℃で融点を観察したところ、いずれの結晶も180℃で融解した。このことは、両結晶の融点が必ずしも同一であることを意味しているとは限らず、例えば、含水結晶の場合には、加熱昇温中に外観上変化することなく、含水結晶から無水結晶に変わり、この無水結晶の融解現象を観察していることが考えられる。
(5)比旋光度(無水物として)
含水結晶、無水結晶とも、
[α]D 20 +207.9°(c=5.0、H2O)
(6)紫外線吸収スペクトル
含水結晶、無水結晶とも、水溶液にして測定すると特徴ある吸収は示さない。
(7)赤外線吸収スペクトル
含水結晶又は無水結晶の粉末2mgをそれぞれ乾燥KBr 200mgと攪拌、混合して透明なタブレットを作成し、赤外線吸収スペクトルを測定した。結果は、含水結晶、無水結晶ともほぼ同一のパターンを示した。図5に含水結晶の結果を示す。
(8)溶解度(無水物として)
含水結晶、無水結晶ともに、25℃で水100mlに対し、約163g溶解する。
(9)甘味度(無水物として)
マルトシルグルコシド25%水溶液の甘味は、蔗糖10%水溶液のそれとほぼ同等であることから、蔗糖の約40%の甘味度である。なお、その甘味の質は、極めて優れている。
(10)呈色反応
含水結晶、無水結晶ともアントロン−硫酸反応で緑色を呈し、フェーリング氏液還元反応、よう素反応は陰性。
(11)構造(無水物として)
(a)1N−硫酸で加水分解するとD−グルコースのみを生成する。
(b)グルコアミラーゼの作用により、グルコース1モルとトレハロース1モルを生成した。
(c)炭素核磁気共鳴分析(13C−NMR)の結果を図6に示す。
クラウス・ボック(KLAUS BOCK)等が『アドバンス・イン・カーボハイドレート・ケミストリー・アンド・バイオケミストリー(Advances in Carbohydrate Chemistry and Biochemistry)』、第42巻、第193乃至225頁(1984年)で報告している標準物質、α−D−グルコピラノース、α,α−トレハロース及びマルトオリゴ糖の化学シフトより、各炭素を帰属し、本物質は、O−α−D−グルコピラノシル−(1→4)−α−D−グルコピラノシル α−D−グルコピラノシドすなわちマルトシルグルコシドの構造を有していると判断される。
(12)粉末X線回折
エフ・エイチ・ストドーラ(F.H.Stodola)等が、『ジャーナル・オブ・ザ・アメリカン・ケミカル・ソサイエティー(Journal of the American Chemical Society)』、第78巻、第2514乃至2518頁(1956年)に報告されている方法に準じて、結晶マルトシルグルコシドのCuKα線を使用した粉末X線回折図形を測定した。含水結晶の結果を図7に、無水結晶の結果を図8に示した。図7、図8の結果より明らかなように含水結晶は粉末X線回折法における主な回折角(2θ)として7.9°、13.2°、17.2°及び22.6°を有し、また、無水結晶は7.7°、13.5°、17.6°及び23.6°を有する。
【0070】
以上の事実より本発明の結晶は、従来全く知られていないマルトシルグルコシドの結晶であると判断される。
【0071】
【実験B−2 結晶マルトシルグルコシドと非晶質マルトシルグルコシドに及ぼす吸湿性とその影響】
含水結晶マルトシルグルコシド、無水結晶マルトシルグルコシド及び非晶質マルトシルグルコシドをそれぞれ、粉末状態で約1gずつポリエチレン製容器にとり、相対湿度90.1%の高湿度雰囲気に放置して、経時的にそれらの水分を測定し、粉末の状態の変化を観察した。試料としては、含水結晶及び無水結晶は、実験B−1の方法で調製したものを用い、非晶質は、その含水結晶を脱イオン水で溶解し、真空乾燥して調製した。結果は、表5にまとめた。
【0072】
【表5】
【0073】
表5の結果から明らかなように、非晶質マルトシルグルコシドは、著しく吸湿して固結し、容易に流動性を失うことが判明した。これに対して、含水結晶は、吸湿が少なく、流動性を保持して、取扱い容易であることが判明した。また、無水結晶は、吸湿するものの、外観上変化なく、流動性を保持することから、無水結晶から含水結晶に変化して、安定しているものと考えられる。
【0074】
【実験B−3 急性毒性試験】
マウスを使用して、実験B−1の方法で調製したマルトシルグルコシドの含水結晶及び無水結晶をそれぞれに経口投与して急性毒性テストを行った。その結果、これら結晶マルトシルグルコシドは低毒性の物質で、投与可能な最大投与量においても死亡例は認められなかった。したがって、正確な値はいえないが、そのLD50値は、いずれも50g/kg以上であった。
【0075】
以下、本発明の結晶マルトシルグルコシドの製造方法を実施例Aで、その用途を実施例Bで示す。
【0076】
【実施例A−1】
純度95%のマルトペンタオース(株式会社林原生物化学研究所製造)50重量部を水200重量部に加熱溶解し、pH7.0、温度40℃に調整した後、実験A−2の方法で調製した非還元性糖質生成酵素を、マルトペンタオースグラム当たり5単位になるように加え、24時間反応させた。この反応液を加熱して、酵素を失活させた。本液には、マルトテトラオシルグルコシドを固形物当たり約83%含有していた。本液を固形物濃度約50%に濃縮し、冷室に放置し、マルトテトラオシルグルコシドの結晶を析出させ、濾過して、結晶マルトテトラオシルグルコシドを採取した。
【0077】
本結晶マルトテトラオシルグルコシド10重量部を水100重量部に加熱溶解し、pH5.5、温度50℃に調整し、β−アミラーゼ(ナガセ生化学工業株式会社製造、商品名#1500)を固形物グラム当たり20単位になるように加えた。24時間反応させた後、100℃で20分間加熱して、酵素を失活させた。本液にはマルトシルグルコシドを固形物当たり約58%含有しており、その他にマルトースと少量のマルトトリオースが含まれていた。
【0078】
本液は、常法にしたがって、活性炭にて脱色し、イオン交換樹脂(H型及びOH型)にて脱塩し、固形物濃度約50%に濃縮した。この濃縮液を塩型強酸性カチオン交換樹脂(オルガノ株式会社製造、商品名XT−1016、Na型)を充填したジャケット付きステンレス製カラム(5.4cm×4mを4本直列に接続)に、60℃、SV0.4でチャージし、ついで、60℃温水で溶出してマルトシルグルコシド高含有画分を採取した。本液は、固形物当たり約92%のマルトシルグルコシドを含有していた。
【0079】
本液は、常法にしたがって、活性炭にて脱色し、イオン交換樹脂(H型及びOH型)にて脱塩し、固形物濃度約80%に濃縮し、これを助晶缶にとり、結晶マルトシルグルコシドを種晶として2%添加し、徐冷しつつ、ゆっくり攪拌しながら助晶した。得られたマスキットは、バスケット型遠心機で分蜜し、少量の水で洗浄したのち、乾燥した。純度99.4%の含水結晶マルトシルグルコシドを採取した。
【0080】
本品は、実質的に吸湿性を示さず、取扱いが容易であり、甘味料、呈味改良剤、品質改良剤、安定剤、賦形剤などとして飲食物、化粧品、医薬品、成形物などの各種組成物に有利に利用できる。
【0081】
【実施例A−2】
炭酸カルシウム0.1%を含む濃度約20%の馬鈴薯澱粉を、pH6.0に調整した後、α−アミラーゼ(ノボノルディスク インダストリー社製造、商品名ターマミール60L)を澱粉固形物グラム当たり0.3%加え、95乃至100℃に加熱して、澱粉を糊化、液化した後、酵素を加熱失活させてDE19.5の液化液を得た。
【0082】
本液をpH6.2、温度40℃に調整し、これに実験A−2の方法で調製した非還元性糖質生成酵素を澱粉グラム当たり3単位、イソアミラーゼ(株式会社林原生物化学研究所製造)を1,000単位の割合となるように加え、72時間反応させた。この反応液を加熱して酵素を失活させた後、冷却し、pHを5.5、温度50℃に調整した後、β−アミラーゼ(ナガセ生化学工業株式会社製造、商品名#1500)を澱粉固形物グラム当たり50単位になるように加え、24時間反応させた。この反応液を加熱して、酵素を失活させた。本液には、マルトシルグルコシドを固形物当たり約21%含有していた。
【0083】
これを実施例A−1と同様に精製、濃縮し、塩型強酸性カチオン交換樹脂を用いるカラムクロマトグラフィーにかけて、マルトシルグルコシド高含有画分を採取した。本液は、固形物当たり約89%のマルトシルグルコシドを含有していた。
【0084】
本液は常法にしたがって、活性炭にて脱色し、イオン交換樹脂(H型及びOH型)にて脱塩し、固形物濃度約85%に濃縮し、結晶マルトシルグルコシドを、種結晶として2%添加し、徐冷しつつゆっくり攪拌しながら、助晶した。得られたマスキットは、バスケット型遠心機で分蜜し、少量の水で洗浄した後、乾燥した。純度98.1%の含水結晶マルトシルグルコシドを採取した。
【0085】
本品は、実質的に吸湿性を示さず、取扱いが容易であり、甘味料、呈味改良剤、品質改良剤、安定剤、賦形剤などとして飲食物、化粧品、医薬品、成形物などの各種組成物に有利に利用できる。
【0086】
【実施例A−3】
澱粉部分分解物(松谷化学工業株式会社製造、商品名パインデックス#4)を用いて、濃度20%、pH5.5、温度45℃に調整し、イソアミラーゼを澱粉部分分解物グラム当たり500単位加え、24時間反応し、澱粉由来のα−1,6結合を分解した。反応液を100℃に加熱し、10分間保った後、40℃に冷却し、pHを6.5に調整した。これに実験A−2の方法で調製した非還元性糖質生成酵素を固形物グラム当たり5単位加え、48時間反応させ、その反応液を100℃に加熱し、10分間保った後、冷却した。温度を50℃に調整した後、β−アミラーゼを固形物グラム当たり50単位、α−アミラーゼを10単位となるように加え、24時間反応させた後、100℃で20分間加熱し、酵素を失活させた。本液には、マルトシルグルコシドを固形物当たり約24%含有していた。
【0087】
これを実施例A−1と同様に、精製、濃縮し、塩型強酸性カチオン交換樹脂を用いるカラムクロマトグラフィーにかけてマルトシルグルコシド高含有画分を採取した。本液は、固形物当たり約91%のマルトシルグルコシドを含有していた。
【0088】
本液は、常法にしたがって、活性炭にて脱色し、イオン交換樹脂(H型及びOH型)にて脱塩し、固形物濃度約85%に濃縮し、結晶マルトシルグルコシドを、種晶として3%添加し、ゆっくり攪拌しながら助晶し、晶出率約45%のマスキットを得た。
【0089】
本マスキットを乾燥塔上のノズルより150kg/cm2の高圧で噴霧した。 これと同時に85℃の熱風を乾燥塔の上部より送風し、乾燥塔底部に設けた移送金網コンベア上に結晶粉末を捕集し、コンベアの下より45℃の温風を送りつつ、該粉末を乾燥塔外に徐々に移動させて取りだした。この粉末結晶を熟成塔に充填し、温風を送りつつ、10時間熟成させ、結晶化と乾燥を完了し、含水結晶マルトシルグルコシド含有粉末を得た。
【0090】
本品は、実質的に吸湿性を示さず、取扱いが容易であり、甘味料、呈味改良剤、品質改良剤、安定化剤、賦形剤などとして飲食物、化粧品、医薬品、成形物などの各種組成物に有利に利用できる。
【0091】
【実施例A−4】
実施例A−3と同様の方法で澱粉部分分解物にイソアミラーゼ、非還元性糖質生成酵素、次いで、β−アミラーゼとα−アミラーゼを作用させた後、分離、精製して得られたマルトシルグルコシド高含有液を濃度約80%まで濃縮した。この濃縮液を助晶缶にとり、結晶マルトシルグルコシドを種晶として2%加え、ゆっくり攪拌しながら助晶し、次いで、バットに取り出し、ブロックを作製した。ブロックは、約25℃で2日間静置し、熟成させた後、切削型粉砕機で粉砕し、流動乾燥し、分級し、含水結晶マルトシルグルコシド含有粉末を得た。
【0092】
本品は、実質的に吸湿性を示さず、取扱いが容易であり、甘味料、呈味改良剤、品質改良剤、安定化剤、賦形剤などとして飲食物、化粧品、医薬品、成形物などの各種組成物に有利に利用できる。
【0093】
【実施例A−5】
実施例A−1の方法で得た含水結晶マルトシルグルコシドを100℃で一夜減圧乾燥して、水分約0.2%の無水結晶マルトシルグルコシドを得た。
【0094】
本品は、室内に放置すると吸湿し、水分約10%の含水結晶マルトシルグルコシドに容易に戻り安定化する。本無水結晶マルトシルグルコシドは、種晶として有利に用いることができる他、吸湿剤、脱水剤、化学原料などとして利用することも有利に用いることができる。更に、飲食物、化粧品、医薬品、成形物などの各種組成物に有利に用いることができる。
【0095】
【実施例A−6】
トレハロース1重量部及び澱粉部分分解物(松谷化学工業株式会社製造、商品名パインデックス#4)1重量部を水3重量部に加熱溶解し、温度65℃、pH6.0に調整し、これにバチルス・ステアロサーモフィラス由来のシクロマルトデキストリン・グルカノトランスフェラーゼ(株式会社林原生物化学研究所製造)を澱粉部分分解物グラム当たり10単位加えて24時間反応の後、酵素を加熱失活させた。次いで、温度55℃に調整し、これにプルラナーゼ(株式会社林原生物化学研究所製造)及びβ−アミラーゼを澱粉部分分解物グラム当たりそれぞれ25単位、50単位加えて、24時間反応させて、これら酵素を加熱失活させた。この反応液には、マルトシルグルコシドを固形物当たり約25%含有していた。
【0096】
これを実施例A−1と同様に精製し、塩型強酸性カチオン交換樹脂を用いるカラムクロマトグラフィーにかけてマルトシルグルコシド高含有画分を得、これを脱色、脱塩し、濃縮、助晶し、バットに取り出してブロックを作製した。本ブロックを切削、乾燥、分級して、含水結晶マルトシルグルコシド含有粉末を原料当たり収率約17%で得た。
【0097】
本品は、実質的に吸湿性を示さず、取扱いが容易であり、甘味料、呈味改良剤、品質改良剤、安定剤、賦形剤などとして、飲食物、化粧品、医薬品、成形物などの各種組成物に有利に利用できる。
【0098】
【実施例B−1 甘味料】
実施例A−1の方法で得た高純度含水結晶マルトシルグルコシド1重量部に、α−グリコシルステビオシド(東洋精糖株式会社販売、商品名αGスイート)0.05重量部を均一に混合し、顆粒成形機にかけて、顆粒状甘味料を得た。本品は、甘味の質が優れ、蔗糖の約2倍の甘味度を有し、甘味度当たりカロリーは、蔗糖の約1/2に低下している。本甘味料は、低カロリー甘味料として、カロリー摂取を制限している肥満者、糖尿病者などのための低カロリー飲食物などに対する甘味付けに好適である。また、本甘味料は、虫歯誘発菌による酸の生成が少なく、不溶性グルカンの生成も少ないことより、虫歯を抑制する飲食物などに対する甘味付けに好適である。
【0099】
【実施例B−2 ハードキャンデー】
55%蔗糖溶液100重量部に実施例A−3の方法で得た含水結晶マルトシルグルコシド含有粉末30重量部を加熱混合し、次いで減圧下で水分2%未満になるまで加熱濃縮し、これにクエン酸1重量部及び適量のレモン香料と着色料とを混和し、常法にしたがって成形し、製品を得た。本品は、歯切れ、呈味良好で、蔗糖の晶出も起こらない高品質のハードキャンデーである。
【0100】
【実施例B−3 いちごジャム】
生いちご150重量部、蔗糖60重量部、マルトース20重量部、実施例A−4の方法で得た含水結晶マルトシルグルコシド粉末40重量部、ペクチン5重量部及びクエン酸1重量部をなべで煮詰め、ビン詰して製品を得た。本品は、風味、色調とも良好なジャムである。
【0101】
【実施例B−4 クリームウエファース】
実施例A−5の方法で得た高純度無水結晶マルトシルグルコシド2,000重量部、ショートニング1,000重量部、レシチン1重量部、レモンオイル1重量部、バニラオイル1重量部を、常法により配合して得たクリームを加温して40乃至45℃に保ちウエファースに挟んでクリームウエファースを製造した。本品は、クリームの溶け具合がなめらかで風味も良好である。
【0102】
【実施例B−5 加糖練乳】
原乳100重量部に実施例A−2の方法で得た高純度含水結晶マルトシルグルコシド5重量部を溶解し、プレートヒーターで加熱殺菌し、次いで濃度約70%に濃縮し、無菌状態で缶詰して製品を得た。本品は、温和な甘味で、風味もよく、乳幼児食品、フルーツ、コーヒー、ココア、紅茶などの調味用に有利に利用できる。
【0103】
【実施例B−6 乳酸飲料】
脱脂乳10重量部を80℃で20分間加熱殺菌した後、40℃に冷却し、これにスターター0.3重量部を加えて約37℃で10時間醗酵させた。次いで、これをホモゲナイズした後、実施例A−2の方法で得た高純度含水結晶マルトシルグルコシド5重量部及び異性化糖シラップ2重量部を加えて70℃に保って殺菌した。これを冷却し、適量の香料を加え、ビン詰して製品を得た。本品は、風味、甘味が酸味とよく調和した高品質の乳酸飲料である。
【0104】
【実施例B−7 粉末ジュース】
噴霧乾燥により製造したオレンジ果汁粉末33重量部に対し、実施例A−2の方法で得た高純度含水結晶マルトシルグルコシド50重量部、蔗糖10重量部、無水クエン酸0.65重量部、リンゴ酸0.1重量部、L−アスコルビン酸0.1重量部、クエン酸ソーダ0.1重量部、プルラン0.5重量部、粉末香料適量をよく混合撹拌し、粉砕し微粉末にしてこれを流動層造粒機に仕込み、排風温度40℃とし、これに、実施例A−2の方法で得た高含有マルトシルグルコシド濃縮液をバインダーとしてスプレーし、30分間造粒し、計量、包装して製品を得た。本品は、果汁含有率約30%の粉末ジュースである。また、本品は異味、異臭がなく、吸湿固結も起こさず長期に安定であった。
【0105】
【実施例B−8 チョコレート】
カカオペースト40重量部、カカオバター10重量部、蔗糖20重量部、実施例A−1の方法で得た高純度含水結晶マルトシルグルコシド30重量部を混合してレファイナーに通して粒度を下げた後、コンチェに入れて50℃で2昼夜練り上げる。この間に、レシチン0.5重量部を加え充分に混和分散させた。次いで、温度調節機で31℃に調節し、バターの固まる直前に型に流し込み、振動機でアワ抜きを行い、10℃の冷却トンネルを20分間くぐらせて固化させた。これを型抜きして包装し製品を得た。本品は、吸湿性がなく、色、光沢共によく、内部組織も良好で、口中でなめらかに溶け、上品な甘味とまろやかな風味を有する。
【0106】
【実施例B−9 チューインガム】
ガムベース3重量部を柔らかくなる程度に加熱溶融し、これに無水結晶マルチトール(株式会社林原商事販売 登録商標マビット)4重量部及び実施例A−2の方法で得た高純度含水結晶マルトシルグルコシド3重量部とを加え、更に適量の香料と着色料とを混合し、常法にしたがって、ロールにより練り合わせ、成形、包装して製品を得た。本品は、テクスチャー、風味とも良好なチューインガムである。
【0107】
【実施例B−10 カスタードクリーム】
コーンスターチ100重量部、実施例A−3の方法で得た含水結晶マルトシルグルコシド含有粉末100重量部、マルトース(株式会社林原商事販売 登録商標サンマルト)80重量部、蔗糖20重量部及び食塩1重量部を充分に混合し、鶏卵280重量部を加えて撹拌し、これに沸騰した牛乳1,000重量部を徐々に加え、更に、これを火にかけて撹拌を続け、コーンスターチが完全に糊化して全体が半透明になった時に火を止め、これを冷却して適量のバニラ香料を加え、計量、充填、包装して製品を得た。本品は、なめらかな光沢を有し、温和な甘味で美味である。
【0108】
【実施例B−11 ういろうの素】
米粉90重量部に、コーンスターチ20重量部、実施例A−6の方法で得た含水結晶マルトシルグルコシド含有粉末120重量部、プルラン4重量部を均一に混合してういろうの素を製造した。ういろうの素と適量の抹茶と水とを混練し、これを容器に入れて60分間蒸し上げて抹茶ういろうを製造した。本品は、照り、口当たりも良好で、風味も良い。また、澱粉の老化も抑制され、日持ちもよい。
【0109】
【実施例B−12 即席コーンポタージュスープ】
α−化コーン粉末30重量部、α−化小麦粉5重量部、α−化ポテトスターチ4重量部、α−化ワキシーコーンスターチ12重量部、実施例A−3の方法で得た含水結晶マルトシルグルコシド含有粉末8重量部、グルタミン酸ナトリウム5重量部、食塩8.5重量部、脱脂粉乳7重量部、オニオンパウダー0.5重量部を磨砕してよく混合した後、これにソルビタン脂肪酸エステル0.5重量部と植物性硬化油9重量部とを加熱融解したものを添加して混合し、更に、乳糖10重量部を加えて混合し、これを実施例B−7と同様に流動層造粒機に仕込んで少量の水をスプレーし、造粒した後、70℃の熱風で乾燥し、篩別して即席コーンポタージュスープを製造した。本品は、熱湯を注げば、容易に溶解、分散し、風味の優れたスープとなる。
【0110】
【実施例B−13 べったら漬の素】
実施例A−4の方法で得た含水結晶マルトシルグルコシド含有粉末4重量部、甘草製剤0.05重量部、リンゴ酸0.008重量部、グルタミン酸ナトリウム0.07重量部、ソルビン酸カリウム0.03重量部及びプルラン0.2重量部を均一に混合してべったら漬の素を製造した。大根30kgを常法にしたがって、食塩により下漬し、次いで蔗糖で中漬したものを、本べったら漬の素4kgで調製した調味液に漬けてべったら漬を製造した。本品は、色、艶、香気ともに良好で、適度の甘味を有し、歯切れもよかった。また、本品は、酸敗しにくく長期間安定であった。
【0111】
【実施例 B−14 経管栄養剤】
実施例A−1の方法で得た高純度含水結晶マルトシルグルコシド20重量部、グリシン1.1重量部、グルタミン酸ナトリウム1重量部、乳酸カルシウム0.4重量部、炭酸マグネシウム0.1重量部、チアミン0.01重量部及びリボフラビン0.01重量部からなる配合物を調製する。この配合物24gずつをラミネートアルミ製小包に充填し、ヒートシールして製品を得た。本品は、1袋分を約33乃至500mlの水に溶解して栄養補給液とし、経管方法により、鼻腔、胃腸などへ投与して使用する。本品は、ヒトのみならず、家畜などへの非経口的栄養補給液としても有利に利用できる。
【0112】
【実施例B−15 経管栄養剤】
実施例A−2の方法で得た高純度含水結晶マルトシルグルコシド580重量部、乾燥卵黄190重量部、脱脂粉乳209重量部、塩化ナトリウム4.4重量部、塩化カリウム1.85重量部、硫酸マグネシウム4重量部、チアミン0.01重量部、アスコルビン酸ナトリウム0.1重量部、ビタミンEアセテート0.6重量部及びニコチン酸アミド0.04重量部からなる配合物を調製する。この配合物25gずつを、ラミネートアルミ製小包に充填し、ヒートシールして製品を得た。本品は、1袋分を約150乃至300mlの水に溶解して、栄養補給液とし、経管方法により鼻腔、食道、胃などへ投与して使用する。
【0113】
【実施例B−16 外傷治療用膏薬】
実施例A−1の方法で得た高純度含水結晶マルトシルグルコシド300重量部及び結晶マルトース200重量部に、ヨウ素3重量部を溶解したメタノール50重量部を加え混合し、更に10%プルラン水溶液200重量部を加えて混合し、適度の延び、付着性を示す外傷治療用膏薬を得た。本品は、治癒期間が短縮され、創面もきれいに治る。
【0114】
【実施例B−17 インターフェロン液剤】
ヒト天然型インターフェロン−γ標品(株式会社林原生物学研究所製造、コスモ・バイオ株式会社販売)を、常法にしたがって、固定化抗ヒトインターフェロン−γ抗体カラムにかけ、該標品に含まれるヒト天然型インターフェロン−γを吸着させ、安定剤である牛血清アルブミンを素通りさせて除去し、次いで、pHを変化させて、ヒト天然型インターフェロン−γを実施例A−1の方法で得た高純度含水結晶マルトシルグルコシドを7%含有する生理食塩水を用いて溶出した。本液を精密濾過し、無菌的にバイアルビンに充填して、ml当たりヒト天然型インターフェロン−γを105単位含有する液剤を得た。本品は、1日当たり、大人 1乃至20ml程度が経口的又は非経口的に投与され、ウイルス性疾患、アレルギー性疾患、リューマチ、糖尿病、悪性腫瘍などの治療に有利に利用できる。本品は、マルトシルグルコシドが安定剤として作用し、4℃又は25℃で20日間放置しても、その活性をよく維持している。
【0115】
【実施例B−18 ツモア・ネクロシス・ファクター液剤】
ヒト天然型ツモア・ネクロシス・ファクター−α標品(株式会社林原生物化学研究所製造、コスモ・バイオ株式会社販売)を、常法にしたがって、固定化抗ヒトツモア・ネクロシス・ファクター−α抗体カラムにかけ、該標品に含まれるヒト天然型ツモア・ネクロシス・ファクター−αを吸着させ、安定剤である牛血清アルブミンを素通りさせて除去し、次いで、pHを変化させて、ヒト天然型ツモア・ネクロシス・ファクター−αを実施例A−1の方法で得た高純度含水結晶マルトシルグルコシドを10%含有する生理食塩水を用いて溶出した。本液を精密濾過し、無菌的にバイアルビンに充填して、ml当たりヒト天然型ツモア・ネクロシス・ファクター−αを104単位含有する液剤を得た。本品は、1日当たり、大人1乃至20ml程度が経口的又は非経口的に投与され、ウイルス性疾患、アレルギー性疾患、リューマチ、糖尿病、悪性腫瘍などの治療に有利に利用できる。本品は、マルトシルグルコシドが安定剤として作用し、4℃又は25℃で20間放置しても、その活性をよく維持している。
【0116】
【実施例 B−19 インターフェロン錠剤】
ヒト天然型インターフェロン−α標品(株式会社林原生物化学研究所製造、コスモ・バイオ株式会社販売)を、常法にしたがって、固定化抗ヒトインターフェロン−α抗体カラムにかけ、該標品に含まれるヒト天然型インターフェロン−αを吸着させ、安定剤である牛血清アルブミンを素通りさせて除去し、次いでpHを変化させて、ヒト天然型インターフェロン−αを実施例A−1の方法で得た高純度含水結晶マルトシルグルコシドを5%含有する生理食塩水を用いて溶出した。本液を精密濾過し、約20倍量の無水結晶マルトース粉末(株式会社林原商事販売、商品名ファイントースT)に加えて脱水、粉末化し、これを打錠機にて打錠し、1錠(約200mg)当たりヒト天然型インターフェロン−αを約150単位含有する錠剤を得た。本品は、舌下錠などとして、1日当たり、大人1乃至10錠程度が経口的に投与され、ウイルス性疾患、アレルギー性疾患、リューマチ、糖尿病、悪性腫瘍などの治療に有利に利用できる。とりわけ、近年、患者数の急増しているエイズ、肝炎などの治療剤として有利に利用できる。本品は、マルトシルグルコシドと共にマルトースが安定剤として作用し、室温で放置してもその活性を長期間よく維持する。
【0117】
【実施例B−20 糖衣錠】
重量150mgの素錠を芯剤とし、これに実施例A−2の方法で得た高純度含水結晶マルトシルグルコシド45重量部、プルラン(平均分子量20万)2重量部、水30重量部、タルク25重量部及び酸化チタン3重量部からなる下掛け液を用いて錠剤重量が約230mgになるまで糖衣し、次いで、同じ含水結晶マルトシルグルコシド含有粉末65重量部、プルラン1重量部及び水34重量部からなる上掛け液を用いて糖衣し、更に、ロウ液で艶出しして光沢のある外観の優れた糖衣錠を得た。本品は、糖衣掛け時の作業性が優れているだけでなく、耐衝撃性にも優れており、高品質を長期間維持する。
【0118】
【実施例B−21 乳液】
ポリオキシエチレンベヘニルエーテル0.5重量部、テトラオレイン酸ポリオキシエチレンソルビトール1重量部、親油型モノステアリン酸グリセリン1重量部、ベヘニールアルコール0.5重量部、アボガド油1重量部、実施例A−2の方法で得た高純度含水結晶マルトシルグルコシド3.5重量部、α−グリコシルルチン1重量部、ビタミンE及び防腐剤の適量を、常法にしたがって加熱溶解し、これに1,3−ブチレングリコール5重量部、カルボキシビニルポリマー0.1重量部及び精製水85.3重量部を加え、ホモゲナイザーにかけ、乳化し、乳液を製造した。本品は、保湿性ある乳液で、日焼け止め、色白剤などとして有利に利用できる。
【0119】
【実施例B−22 スキンクリーム】
モノステアリン酸ポリオキシエチレングリコール2重量部、自己乳化型モノステアリン酸グリセリン5重量部、α−グリコシルルチン2重量部、流動パラフィン1重量部、トリオクタン酸グリセリル10重量部、実施例A−1の方法で得た高純度含水結晶マルトシルグルコシド1重量部、マルチトール3重量部及び防腐剤の適量を、常法にしたがって加熱溶解し、これに1,3−ブチレングリコール5重量部及び精製水66重量部を加え、ホモゲナイザーにかけて乳化し、更に、香料の適量を加えて撹拌混合し、クリームを製造した。本品は、伸びの良いクリームで、日焼け止め、美肌剤、色白剤などとして有利に使用できる。
【0120】
【実施例B−23 練歯磨】
第二リン酸カルシウム45重量部、ラウリル硫酸ナトリウム1.5重量部、グリセリン25重量部、ポリオキシエチレンソルビタンラウレート0.5重量部、実施例A−2の方法で得た高純度含水結晶マルトシルグルコシド15重量部、サッカリン0.02重量部及び防腐剤0.05重量部を水13重量部と混合して練歯磨を得た。本品は、光沢、洗浄力も良好で、練歯磨として好適である。
【0121】
【実施例B−24 肥料杭】
配合肥料(N=14%、P2O5=8%、K2O=12%)、プルラン、実施例 A−6の方法で得た含水結晶マルトシルグルコシド含有粉末、硫酸カルシウム及び水の割合を重量でそれぞれ70、5、5、15及び5として充分混合した後、押出機(L/D=20、圧縮比=1.8、ダイスの口径=30mm)で80℃に加熱して肥料杭を製造した。本品は、肥料用容器が不要で取扱い容易であり、全層施肥に適した強度を有し、更に配合割合を変えることにより肥料成分の溶出速度を調節できる。必要ならば、この肥料杭に植物ホルモン、農業用薬剤及び土壌改良剤等の混合も容易である。
【0122】
【発明の効果】
上記から明らかなように、本発明の結晶マルトシルグルコシドは、実質的に非吸湿性乃至難吸湿性で流動性良好であって取扱い易く、水に溶解し易い物質であり、適度な粘性を有し、良質な甘味を有している。また、結晶マルトシルグルコシドは、化学的に安定であり、褐変反応を起こし易いアミノ酸、オリゴペプチド、更には、有効成分、活性の失われ易い生理活性物質などを安定化し得る性質を有している。加えて、浸透圧調節性、賦活性、照り付与性、保湿性、他の糖の晶出防止、難発酵性、澱粉の老化防止性などの性質を具備している。これら諸性質は、飲食物、化粧品、医薬品、成形物など各種組成物の製造に有利に利用できる。
【0123】
したがって、本発明の結晶マルトシルグルコシドとその製造方法並びに用途の確立は、飲食物、化粧品、医薬品分野における産業的意義が極めて大きい。
【図面の簡単な説明】
【図1】リゾビウム・スピーシーズ M−11由来の非還元性糖質生成酵素の活性に及ぼす温度の影響を示す図である。
【図2】リゾビウム・スピーシーズ M−11由来の非還元性糖質生成酵素の活性に及ぼすpHの影響を示す図である。
【図3】リゾビウム・スピーシーズ M−11由来の非還元性糖質生成酵素の温度安定性を示す図である。
【図4】リゾビウム・スピーシーズ M−11由来の非還元性糖質生成酵素のpH安定性を示す図である。
【図5】含水結晶マルトシルグルコシドの赤外線吸収スペクトルを示す図である。
【図6】マルトシルグルコシドの炭素核磁気共鳴分析結果を示す図である。
【図7】含水結晶マルトシルグルコシドの粉末X線回折図形を示す図である。
【図8】無水結晶マルトシルグルコシドの粉末X線回折図形を示す図である。[0001]
[Industrial application fields]
The present invention relates to a novel crystalline carbohydrate and a production method and use thereof, and particularly relates to crystalline maltosyl glucoside and a production method and use thereof.
[0002]
[Prior art]
Maltotriose is a trisaccharide represented by the formula: O-α-D-glucopyranosyl- (1 → 4) -O-α-D-glucopyranosyl- (1 → 4) -D-glucopyranose. It has long been known as a sweet saccharide contained in the This carbohydrate is characterized by low sweetness and is used in compositions such as various beverages, processed foods, and favorite foods.
[0003]
However, since maltotriose is a reducing sugar, it has a drawback that it easily undergoes browning reaction with proteins, amino acids and the like contained in beverages, processed foods, and favorite foods, and is susceptible to alteration and deterioration. Therefore, the present inventors have intensively studied to eliminate this drawback, and have previously formed a trehalose structure from a reduced starch partial degradation product having a glucose polymerization degree of 3 or more described in Japanese Patent Application No. 5-349216. Non-reducing from maltotriose by the action of an enzyme that produces a non-reducing saccharide having the same (in this specification, this enzyme may be simply referred to as “non-reducing saccharide-forming enzyme”). It has been found to produce sex maltosyl glucoside. However, this non-reducing carbohydrate maltosyl glucoside powder is amorphous and physically unstable, and it is desired to establish more stable crystals.
[0004]
On the other hand, regarding maltosyl glucoside itself, for example, Von Werner Fischer et al., “Hoppe-Seiler's Zeitshirisfurt Physiology” 350, 1137 to 1147 (1969), the method of extracting from microbial cells, Shinkiti Koto et al., “Britin of Chemical Society of Reported in Japan (Bulletin of Chemical Society of Japan), Vol. 59, pp. 411-414 (1986), and also by Hans Peter Beh The preparation method is known by the chemical synthesis method reported by Cell (Hans Peter Wesel) et al. In “Helvetica Chimica Acta”, Vol. 74, pages 682 to 695 (1991). Although there is no description about the crystal, it is not yet known.
[0005]
[Problems to be solved by the invention]
The present invention intends to provide a method for establishing crystalline maltosyl glucoside, a method for producing crystalline maltosyl glucoside, and its use.
[0006]
[Means for Solving the Problems]
In order to solve the above problems, the present inventors have continued intensive studies. As a result, non-reducing saccharide-forming enzyme is allowed to act on maltopentaose, which is a partial degradation product of reducing starch, to convert maltopentaose into non-reducing maltotetraosyl glucoside, and then β- The liquid containing maltosyl glucoside obtained by the action of amylase was subjected to column chromatography using a salt-type strongly acidic cation exchange resin, and the liquid containing high maltosyl glucoside obtained by purification was concentrated and stored in a cold room. The present inventors have found a phenomenon in which crystals are precipitated, further elucidated that the crystals are crystalline maltosyl glucosides, established new crystalline maltosyl glucosides, established production methods and uses thereof, and completed the present invention. . At the same time, the presence of water-containing crystals and anhydrous crystals as crystalline maltosyl glucoside was elucidated, and the production method and use thereof were established, thereby completing the present invention.
[0007]
As a method for producing crystalline maltosyl glucoside, any method capable of producing the present crystal may be used. Usually, this is crystallized and collected from a solution containing maltosyl glucoside.
[0008]
In order to produce maltosyl glucoside, a chemical synthesis method may be used, but generally, a biochemical method using a glycosyltransferase or a non-reducing saccharide-forming enzyme is advantageous.
[0009]
As a method using a glycosyltransferase, for example, a glycosyltransferase is allowed to act on an aqueous solution containing trehalose and α-glucosyl saccharide, and for example, maltosyl glucoside, maltotriosyl glucoside, maltotetraosyl glucoside, etc. α-D-oligoglucosyl glucoside may be produced. If necessary, β-amylase or β-amylase and a starch debranching enzyme such as pullulanase or isoamylase are allowed to act on the maltosyl glucoside. It can also be advantageously carried out.
[0010]
In this case, the α-glucosyl saccharide may be any saccharide that can transfer one or more glucose residues to trehalose by α-1,4 linkage by the glycosyltransferase used. For example,
[0011]
Usually, when the glycosyltransferase is cyclomaltodextrin glucanotransferase (EC 2.4.1.19) or α-amylase (EC 3.2.1.1), for example, starch, gelatinized starch, Amylopectin, amylose, reductive starch partial degradation product, cyclodextrin, dextrin, malto-oligosaccharide, etc. are suitable. In the case of α-glucosidase, malto-oligo such as maltose, maltotriose, maltotetraose, maltopentaose, etc. Sugar, dextrin, sucrose and the like are preferred.
[0012]
In order to produce maltosylglucoside using a non-reducing saccharide-forming enzyme, the enzyme may be allowed to act on high-purity maltotriose, but in general, a reduction with a glucose polymerization degree of 3 or more is possible. A non-reducing saccharide-forming enzyme is allowed to act on the partially degraded starch, and a non-reducing saccharide having a trehalose structure at the terminal, for example, α- such as maltosyl glucoside, maltotriosyl glucoside, maltotetraosyl glucoside, etc. D-oligoglucosyl glucoside may be generated. In this method, as in the case of using glycosyltransferase, if necessary, the starch debranching enzyme can be allowed to act together with β-amylase or β-amylase to increase the content of maltosylglucoside. .
[0013]
The reductive starch partial decomposition product may be anything that can generate maltosyl glucoside by a non-reducing saccharide-forming enzyme, or can generate a saccharide containing a maltosyl glucoside structure. Gelatinized starch, liquefied starch, soluble starch, amylopectin, amylose, dextrin, partially reduced product of reduced starch of DE1 to 40, maltooligosaccharide having a glucose polymerization degree of 3 or more can be advantageously used.
[0014]
As the non-reducing saccharide-forming enzyme used in the present invention, for example, as previously described in the specification of Japanese Patent Application No. 5-349216, the present inventors have already established 1-3 1-3 Higashi, Tsukuba City, Ibaraki Prefecture. Rhizobium sp. M-11 “Accession Number, JIKOH Jojo No. 4130 (FERM) deposited at the Institute of Biotechnology and Industrial Technology Research Institute of the Ministry of International Trade and Industry BP-4130) ”, Arthrobacter sp. Q36“ Accession Number, FERM BP-4316 ”, and other known microorganisms such as Brevibacterium herovolum ATCC 11822, Flavo Bacteria Aquatile erium aquatile IFO3772, Micrococcus luteus IFO3064, Micrococcus roseus ATCC 186, Curtobacterium citreum Ic 15231 Microorganisms capable of producing non-reducing saccharide-forming enzymes such as (Terrabacter tumescens) IFO12960 can be cultured in a nutrient medium, and this culture can be collected and used. If necessary, it can be appropriately purified by known methods. You may use it.
[0015]
The non-reducing saccharide-forming enzyme thus obtained generates a non-reducing saccharide having a trehalose structure at the end from one or more reducing starch partial degradation products selected from a glucose polymerization degree of 3 or more. Have the effect of
[0016]
These enzyme reaction conditions can be adopted as long as the target enzyme reaction proceeds. In general, the substrate concentration is about 1 to 50 w / w% (hereinafter, unless otherwise specified, w The reaction temperature is about 20 to 80 ° C., the reaction pH is about 4 to 10, and the reaction time is about 1 to 100 hours. Enzymes used in these reactions may be immobilized by a known method such as a carrier binding method, a crosslinking method, or a comprehensive method, if necessary, and used for continuous reactions or repeatedly in batch reactions. is there.
[0017]
Enzymatic reactions as described above usually contain about 1 to 67% maltosylglucoside per solid. In order to produce crystalline maltosyl glucoside from this reaction solution, generally, a contaminated substance is separated and purified to obtain a liquid containing a high amount of maltosyl glucoside, which is concentrated and crystallized crystal maltosyl glucoside is crystallized. It is advantageous to collect.
[0018]
As the separation and purification method, for example, a yeast fermentation method, a membrane filtration method, a fractional precipitation method, an alkali treatment method, a chromatography method and the like can be appropriately employed. In particular, by the column chromatography using a salt-type strongly acidic cation exchange resin disclosed in JP-A-58-23799, JP-A-59-148794, etc., contaminating saccharides are removed and maltosyl glucoside is increased. A method of collecting the contained liquid can be advantageously carried out. At this time, it is optional to adopt any of the known fixed bed method, moving bed method, and simulated moving bed method.
[0019]
In order to crystallize maltosylglucoside from the solution containing high maltosylglucoside thus obtained, appropriate conditions are selected depending on the type of crystal. As crystallization conditions, it is a supersaturated solution of maltosyl glucoside, and crystal maltosyl glucoside may be precipitated, and the production method of maltosyl glucoside itself is not limited.
[0020]
Specifically, maltosyl glucoside having a purity of 60% or more is set to a concentration of about 65 to 95% or more, and the temperature of the solution is such that the solution does not freeze and is below the melting point of the crystal. For example, in the case of water-containing crystals, a solution having a water content of about 10% or more is about 10 to 90 ° C, and in the case of anhydrous crystals, a solution having a water content of less than about 10% is about 90 to 150 ° C. Can be crystallized. Anhydrous crystals can also be easily produced by drying the hydrous crystals under reduced pressure or by heating. In addition, in order to adjust the supersaturation degree, viscosity, etc. of the solution at the time of crystallization, for example, it is optional to coexist methanol, ethanol, acetone or the like.
[0021]
The crystallization method usually involves taking a relatively high temperature supersaturated maltosyl glucoside-containing solution in an auxiliary crystal can, and allowing seed crystals to coexist in this, preferably 0.1 to 20%, and slowly cooling while slowly stirring. , Promote crystallization and make a mass kit.
[0022]
The method for producing crystalline maltosyl glucoside from the crystallized mass kit is not limited as long as crystalline maltosyl glucoside can be collected.For example, a known method such as a honey method, a block grinding method, a fluidized granulation method, or a spray drying method can be used. That's fine.
[0023]
For example, the honey method is usually a method of separating the crystalline maltosyl glucoside and honey by applying a basket-type centrifuge, and if necessary, it is easy to spray and wash the crystal with a small amount of cold water. Suitable for producing higher purity crystalline maltosyl glucoside. The other three methods do not separate nectar, so that the resulting crystalline product does not show an improvement in purity but has a high product yield. Therefore, in the case of this product, the crystalline product usually contains sugars derived from raw materials or production processes, such as trehalose, glucose, maltose, maltotriose, maltotetraose, etc. in addition to maltosylglucoside. It is.
[0024]
In the case of the spray drying method, usually, a mass kit having a crystallization rate of about 25 to 60% is sprayed from a nozzle with a high-pressure pump, dried at a temperature at which the crystal powder does not melt, for example, hot air of about 60 to 100 ° C. If dried and aged with warm air, non-hygroscopic or hardly hygroscopic crystal-containing powder can be easily produced.
[0025]
The block pulverization method is usually performed by allowing a mass kit having a crystallization rate of about 10 to 60% to stand for about 0.5 to 5 days to crystallize and solidify the whole into a block shape, which is then pulverized or cut. If crushed and dried, non-hygroscopic and hardly hygroscopic crystal-containing powder can be easily produced.
[0026]
In addition, a maltosyl glucoside-containing aqueous solution is heated and concentrated to a moisture content of less than 5% according to a conventional method to obtain a supersaturated maltosyl glucoside-containing solution in a molten state, and seed crystals are mixed into this solution at a temperature below the melting point of the crystal. It is also optional to produce a non-hygroscopic or hardly hygroscopic crystal-containing solid by forming it into various shapes such as powder, granules, rods, plates, cubes, and the like.
[0027]
The crystalline maltosyl glucoside thus obtained varies in its non-hygroscopicity somewhat depending on the purity of the maltosyl glucoside, but is substantially non-hygroscopic, fluid, and has a concern about adhesion and sticking. It is easy to handle with little, and material and human expenses required for management such as packaging, transportation and storage can be greatly reduced.
[0028]
The crystalline maltosyl glucoside of the present invention is a substantially non-hygroscopic or hardly hygroscopic powder, and has high heat resistance and good stability. , Chewing gum, instant juice, instant soup, granules, excipients such as tablets, bulking agents, powder bases, etc., for example, various compositions such as food, drinks, cosmetics, pharmaceuticals, molded products, as well as reagents, chemical industry It can be advantageously used in various applications such as raw materials.
[0029]
Crystalline maltosyl glucoside changes in physicochemical properties such as melting point and specific optical rotation due to differences in purity. Among these, melting | fusing point falls as the purity of maltosyl glucoside falls, and the range of melting | fusing point becomes wide. For example, the melting point of crystalline maltosyl glucoside having a purity of 88.6% is 138 to 146 ° C. Therefore, the crystalline maltosyl glucoside may be used by appropriately selecting its purity as required.
[0030]
The crystalline maltosyl glucoside of the present invention is soluble in water and has a good quality and moderate sweetness. Moreover, it is digested and absorbed by ingestion and used as a calorie source. Furthermore, it can be used as a sweetener that does not easily cause caries because it is not easily fermented by caries-inducing bacteria. In addition, since it is a good quality sweetener and excipient, it can be advantageously used as a sugar coating for tablets in combination with a binder such as pullulan and hydroxyethyl starch. In addition, it has properties such as body imparting property, shimmering property, moisture retention, viscosity, heat resistance, acid resistance, non-reducing property or low reducing property.
[0031]
These properties possessed by crystalline maltosyl glucoside can be advantageously used for the production of foods, tastes, feeds, foods and other foods, and various compositions such as cosmetics, pharmaceuticals and molded products.
[0032]
The crystalline maltosyl glucoside of the present invention can be used as it is as a seasoning for sweetening. If necessary, for example, flour, glucose, maltose, sucrose, isomerized sugar, honey, maple sugar, sorbitol, dihydrochalcone, stevioside, α-glycosyl stevioside, rebaudioside, glycyrrhizin, L-aspartyl-L-phenylalanine methyl ester, It may be used in combination with one or more suitable amounts of other sweeteners such as saccharin, glycine, alanine, etc., and if necessary, mixed with a bulking agent such as dextrin, starch, lactose, etc. Can also be used.
[0033]
In addition, crystalline maltosyl glucoside powder product is a substantially non-hygroscopic powder, has high heat resistance and good stability, so as an extender, excipient, powder base, etc. If necessary, it is optional to mix with other extenders, excipients, binders, etc., and form into various shapes such as granules, spheres, short bars, plates, cubes and tablets. In addition, the present powder product can be advantageously replaced with a part of flours such as wheat flour, corn grits, starch and the like, for example, for use in confectionery materials, bread making materials, cereal materials and the like.
[0034]
In addition, the sweetness of crystalline maltosyl glucoside matches well with other substances having other tastes such as acidity, salt to taste, astringency, umami, and bitterness, and has high acid resistance and heat resistance. Can be advantageously used for sweetening, taste improvement, and quality improvement. For example, soy sauce, powdered soy sauce, miso, powdered miso, moromi, hashio, sprinkle, mayonnaise, dressing, vinegar, three cups vinegar, powdered sushi vinegar, Chinese food, tentsuyu, noodle soup, sauce, ketchup, grilled meat sauce, curry roux, stew It can be advantageously used as various seasonings such as Nomoto, soup, dashi, compound seasoning, mirin, new mirin, table sugar, coffee sugar. In addition, various Japanese sweets such as rice crackers, hail, rice cakes, rice cakes, manju, oirou, chanterelles, sheep mushrooms, water sheep rice cakes, brocade balls, jellies, castellas, rice balls, bread, biscuits, crackers, cookies, pie Pudding, butter cream, custard cream, cream puff, waffle, sponge cake, donut, chocolate, chewing gum, caramel, candy and other Western confectionery, ice cream, sherbet and other ice confectionery, fruit syrup pickled, syrup such as honey, Paste such as flower paste, peanut paste, fruit paste, spread, fruit such as jam, marmalade, syrup pickles, sugar cane, processed foods of vegetables, pickles such as Fukujin pickles, bedara pickles, thousand pieces pickles, pickles, pickles, etc. , Chinese cabbage pickles Pickled vegetables, meat products such as ham and sausage, fish meat ham, fish sausage, fish products such as kamaboko, chikuwa, tempura, sea urchin, squid salted salt, vinegar kombu, sakisume, fugumirin dried and other delicacies , Paste, wild vegetable, sardine, small fish, shellfish, etc., boiled beans, potato salad, side dish foods such as konbu rolls, dairy products, fish meat, livestock meat, fruit, vegetable bottling, canned food, synthetic Alcoholic beverages such as liquor, western liquor, coffee, cocoa, juice, carbonated beverages, soft drinks such as lactic acid beverages, lactic acid bacteria beverages, pudding mix, hot cake mix, instant food such as instant soup, instant soup, baby food, treatment It can be advantageously used for sweetening various foods and drinks such as foods and drinks, improving taste, and improving quality.
[0035]
Moreover, it can also be used in order to improve the palatability of feed, feed, etc. for domestic animals, poultry, and other domestic animals such as bees, sharks, and fish. In addition, tobacco, toothpaste, lipstick, lip balm, internal medicine, troche, tablets, liver oil drop, mouth freshener, mouth fragrance, mouthwash, various solids, pastes, liquids, etc. It can be advantageously used as a sweetener for use in the mouth, as a taste improver, a taste improver, and further as a quality improver.
[0036]
In addition, crystalline maltosyl glucoside is a stabilizer for soaps, skin creams, body shampoos, hair creams, lip balms, skin beautifiers, hair restorers, osmotic pressure regulators, excipients, moisturizing regulators, viscosity modifiers. It can be advantageously used in cosmetic production as an agent, quality improver and the like.
[0037]
In addition, physiologically active substances such as interferon-α, interferon-β, interferon-γ, tsumore necrosis factor-α, tsumore necrosis factor-β, lymphotoxin, macrophage migration inhibitory factor, colony stimulating factor, transfer factor , Cytokines such as interleukin 2, insulin, growth hormone, prolactin, erythropoietin, follicle stimulating hormone, BCG vaccine, Japanese encephalitis vaccine, measles vaccine, polio vaccine, seedling seedling, tetanus toxoid, hub antitoxin, human immunity Globulin and other vaccines, penicillin, erythromycin, chloramphenicol, tetracycline, streptomycin, kanamycin sulfate and other antibiotics, thiamine, riboflavin Vitamins such as L-ascorbic acid, liver oil, carotenoids, ergosterol, tocopherol, enzymes such as lipase, esterase, urokinase, protease, glucanase, ginseng extract, suppon extract, chlorella extract, propolis, royal jelly extracts, viruses , Active ingredients such as lactic acid bacteria, bifidobacteria, yeast and other active fungi, and active stabilizers, and can be advantageously used in pharmaceutical production as osmotic pressure regulators, excipients, tube feeding nutrients, syrups, etc. . The method of adding the crystalline maltosyl glucoside of the present invention to various compositions such as foods and drinks, cosmetics, pharmaceuticals, and molded products as described above may be included in the process until the composition is completed. Known methods such as mixing, kneading, dissolving, melting, dipping, infiltration, spraying, coating, coating, spraying, pouring, solidification, and crystallization are appropriately selected. The amount to be contained varies depending on the composition, but generally, an amount of 0.1% or more, preferably 0.5% or more is suitable as the crystalline maltosyl glucoside. The composition thus obtained can be used not only for foods and drinks, cosmetics, pharmaceuticals, and molded products that are used orally or parenterally, but also for example, daily necessities, agricultural, forestry and fishery products, and chemical industry products. Have a wide range of uses.
[0038]
Next, the present invention will be described in more detail by experiments.
[0039]
First, in Experiment A, the production, purification, and properties of an enzyme from Rhizobium sp. M-11 as an example of a non-reducing saccharide-forming enzyme will be described, and then from a reduced starch partial degradation product using the enzyme. A preparation example of a non-reducing carbohydrate having a trehalose structure at the end and trehalose will be described. Next, in Experiment B, preparation examples of the crystalline maltosyl glucoside of the present invention and its physicochemical properties will be described.
[0040]
[Experiment A-1 Production of non-reducing carbohydrate-forming enzyme from Rhizobium sp. M-11]
It consists of maltose 2.0 w / v%, peptone 0.5 w / v%, yeast extract 0.1 w / v%, disodium phosphate 0.1 w / v%, monopotassium phosphate 0.1 w / v% and water. The liquid medium was adjusted to pH 7.0. About 100 ml of this medium is placed in a 500 ml Erlenmeyer flask, sterilized by autoclaving at 120 ° C. for 20 minutes, cooled, inoculated with Rhizobium species M-11 (FERM BP-4130), and incubated at 27 ° C. and 130 rpm for 24 hours. The culture was used as a seed culture solution.
[0041]
A fermenter with a volume of 30 l is charged with about 20 l of medium having the same composition as in the case of seed culture, sterilized and cooled to a temperature of 30 ° C., then inoculated with 1 v / v% of the seed culture solution,
[0042]
The non-reducing carbohydrate purified enzyme activity was measured by adding 1 ml of enzyme solution to 4 ml of maltopentaose 1.25 w / v% (50 mM phosphate buffer, pH 7.0) as a substrate, and reacting at 40 ° C. for 60 minutes. Thereafter, the reaction is stopped by heating at 100 ° C. for 10 minutes, the reaction solution is accurately diluted 10 times with deionized water, and the reducing power of the diluted solution is measured by the Somogy Nelson method. As a control, the same measurement is performed using an enzyme solution inactivated by heating at 100 ° C. for 10 minutes in advance. Using the above measurement method, the amount of enzyme that reduces the reducing power corresponding to 1 μmole of maltopentaose per minute was defined as 1 unit.
[0043]
[Experiment A-2 Enzyme Purification]
About 18 liters of the culture solution obtained in Experiment A-1 was treated with an ultrahigh pressure microbial cell disruption device minilab (manufactured by Dainippon Pharmaceutical Co., Ltd.), and the microbial cells contained were crushed. The treatment solution was centrifuged (10,000 rpm, 30 minutes) to obtain about 16 l of supernatant. Ammonium sulfate was dissolved in the liquid so that the degree of saturation was 0.2, and the mixture was allowed to stand at 4 ° C. for 1 hour, and then centrifuged (10,000 rpm, 30 minutes) to recover the supernatant.
[0044]
Further, ammonium sulfate was dissolved in the solution so as to have a saturation degree of 0.6, and allowed to stand at 4 ° C. for 24 hours, and then centrifuged (10,000 rpm, 30 minutes) to recover ammonium sulfate salted-out. The obtained ammonium sulfate salted-out product was dissolved in 10 mM phosphate buffer (pH 7.0), dialyzed against the same buffer for 24 hours, and centrifuged (10,000 rpm, 30 minutes) to remove insoluble matter. Excluded. The dialysate (360 ml) was divided into two portions and subjected to ion exchange column chromatography (gel amount: 300 ml) using DEAE-Toyopearl gel (manufactured by Tosoh Corporation).
[0045]
The enzyme was adsorbed on DEAE-Toyopearl gel and eluted from the column with the same buffer containing sodium chloride. The obtained enzyme activity fraction is dialyzed against the same buffer containing 2M ammonium sulfate, the dialyzed solution is centrifuged (10,000 rpm, 30 minutes) to remove insoluble matters, and the resulting supernatant is butyltoyopearl. Hydrophobic column chromatography (gel amount: 300 ml) using 650 gel (manufactured by Tosoh Corporation) was performed. The adsorbed enzyme was eluted from the column with an ammonium sulfate 2M to 0M linear gradient, and the enzyme activity fraction was recovered. Subsequently, gel filtration chromatography (gel amount: 300 ml) using Toyopearl HW-55 resin (manufactured by Tosoh Corporation) was performed, and the enzyme activity fraction was recovered. Table 1 shows the amount of enzyme activity, specific activity, and yield in each step of purification.
[0046]
[Table 1]
[0047]
When the purity of the purified enzyme preparation obtained as a gel filtration eluate in the step of Table 1 was tested by electrophoresis using polyacrylamide gel (gel concentration 7.5 w / v%), the protein band was single. As a result, the enzyme preparation obtained was an electrophoretically single preparation with high purity.
[0048]
[Experiment A-3 Properties of enzyme]
The purified enzyme preparation obtained in Experiment A-2 was subjected to electrophoresis using SDS-polyacrylamide gel (gel concentration: 10 w / v%), and simultaneously migrated molecular weight marker (manufactured by Nippon Bio-Rad Laboratories, Inc.) The molecular weight of the present enzyme was measured in comparison with the molecular weight of about 77,000 to 87,000 daltons.
[0049]
The purified enzyme preparation was subjected to isoelectric focusing using a polyacrylamide gel (containing 2 w / v% ampoline, Sweden, Pharmacia El Kavy), and after electrophoresis, the pH of the gel was measured. When the isoelectric point was determined, the isoelectric point was about 3.6 to 4.6.
[0050]
The effects of temperature and pH on the enzyme activity were examined according to the activity measurement method. The results are shown in FIG. 1 (effect of temperature) and FIG. 2 (effect of pH). The optimum temperature of the enzyme was about 7.0 ° C. when reacted at pH 7.0 for 60 minutes, and the optimum pH was about 7.0 after reacting at 40 ° C. for 60 minutes. The temperature stability of the enzyme was determined by measuring the remaining enzyme activity after holding the enzyme solution (containing 50 mM phosphate buffer, pH 7.0) at each temperature for 60 minutes, cooling with water. The pH stability was determined by maintaining the enzyme in a 50 mM buffer solution at each pH at 25 ° C. for 16 hours, adjusting the pH to 7, and measuring the remaining enzyme activity. The respective results are shown in FIG. 3 (temperature stability) and FIG. 4 (pH stability). The temperature stability of this enzyme was stable up to around 40 ° C., and the pH stability was about 6 to 9.
[0051]
[Experiment A-4 Preparation of non-reducing carbohydrate]
As substrates, prepare 20% aqueous solutions of glucose, maltose, maltotriose, maltotetraose, maltopentaose, maltohexaose, or maltoheptaose, and prepare the purified enzyme preparations obtained in Experiment A-2 for each. Added at a rate of 2 units per gram of substrate solids, allowed to act at 40 ° C. and pH 7.0 for 48 hours, desalted, and used a Wako Beads WB-T-330 column (manufactured by Wako Pure Chemical Industries, Ltd.). The reaction product was analyzed by high performance liquid chromatography. The high performance liquid chromatography was performed at room temperature, water was flowed as an eluent at a flow rate of 0.5 ml / min, and analysis was performed with a differential refractometer RI-8012 (manufactured by Tosoh Corporation). The results are shown in Table 2.
[0052]
[Table 2]
[0053]
As is apparent from the results in Table 2, each of the remaining substrates and newly generated carbohydrates PI, PII, PIII, PIV, and PV are hardly detected in the reaction product. . Each of the production rates was found to have a high production rate of 85% or more for PII, PIII, PIV and PV having a glucose polymerization degree of 4 or more, although the PI with a glucose polymerization degree of 3 was relatively low. It has been found that no new carbohydrate is produced from glucose or maltose.
[0054]
In order to purify newly produced carbohydrates from each reaction product, after decolorization, desalting and concentration, alkali metal type strongly acidic cation exchange resin (XT-1016, Na+Column fractionation using a mold, a crosslinking degree of 4%, manufactured by Tokyo Organic Chemical Industry Co., Ltd.). The resin is packed in three stainless steel columns with an inner diameter of 2.0 cm and a length of 1 m, connected in series, and the reaction sugar solution is added to the resin at 5 v / v% while maintaining the temperature in the column at 55 ° C. This was fractionated by flowing warm water at 55 ° C. at SV 0.13, and a newly produced high-purity fraction having a carbohydrate content of 97% or more was collected. The obtained high-purity fractions were vacuum-dried to prepare high-purity carbohydrate preparations, respectively. The yield based on the substrate material was about 9% for PI, about 65% for PII, about 82% for PIII, about 80% for PIV, and about 77% for PV, respectively, in terms of solid matter. The purity was 97.5% for PI, 98.6% for PII, 99.5% for PIII, 98.4% for PIV, and 98.4% for PV.
[0055]
The reducing power of these newly produced high-purity carbohydrate preparations was measured by the Somogy Nelson method and expressed in DE. The results are summarized in Table 3.
[0056]
[Table 3]
[0057]
As is apparent from the results in Table 3, only a slight reducing power was observed in any of the samples. The slight reducing power is presumed to be attributable to the reducing malto-oligosaccharide derived from the substrate mixed in and remaining in the sample in a trace amount, and any newly produced carbohydrate is substantially non-reducing. It is judged that.
[0058]
[Experiment A-5 Enzymatic degradation with glucoamylase]
50 mg each of the non-reducing carbohydrate preparation, PI, PII, PIII, PIV or PV prepared in Experiment A-4 was dissolved in 1 ml of 50 mM acetate buffer (pH 4.5), and 1 unit of glucoamylase ( Seikagaku Co., Ltd.) was added and kept at 40 ° C. for 6 hours. After enzymatic degradation, the degradation product was analyzed by high performance liquid chromatography. As a result, only glucose and trehalose were detected as degradation products from any sample. It was. Table 4 shows the results of the detected glucose content, trehalose content, and compositional molar ratio.
[0059]
[Table 4]
[0060]
As is apparent from the results in Table 4, glucoamylase decomposes non-reducing carbohydrate PI into one glucose molecule and one trehalose molecule, and non-reducing carbohydrate PII into two glucose molecules and one trehalose molecule. Non-reducing carbohydrate PIII is decomposed into 3 glucose molecules and 1 trehalose molecule, non-reducing carbohydrate PIV is decomposed into 4 glucose molecules and 1 trehalose molecule, and non-reducing carbohydrate PV is 5 glucose molecules and 1 trehalose molecule. It was found that it was decomposed.
[0061]
Further, considering the reaction characteristics of glucoamylase, the structure of these non-reducing carbohydrates is a carbohydrate in which glucose molecules are linked to trehalose molecules with α-1,4 bonds or α-1,6 bonds. Is a non-reducing saccharide with a
[0062]
From the above results, the reaction by the non-reducing saccharide-forming enzyme of the present invention does not involve lowering the molecular weight and increasing the molecular weight of the substrate, in other words, an intramolecular conversion reaction without changing the degree of glucose polymerization. Non-reducing carbohydrates, PI, PII, PIII, PIV and PV produced by this non-reducing carbohydrate-forming enzyme are α-glucosyl trehalose (also known as α-maltosyl glucoside), α, respectively. -Maltosyl trehalose (also known as α-maltotriosyl glucoside), α-maltotriosyl trehalose (also known as α-maltotetraosyl glucoside), α-maltotetraosyl trehalose (also known as α-maltopentaosyl glucoside) ) And α-maltopentaosyl trehalose (also known as α-maltohexaosyl glucoside) Source (Gn-T: However, G means a glucose residue, n means an integer of 1 or more, and T means α, α-trehalose. ).
[0063]
[Experiment A-6 Preparation of Trehalose and Non-reducing Carbohydrate Having Trehalose Structure at Terminal]
After dissolving 40 parts by weight of a partially decomposed starch (manufactured by Matsutani Chemical Industry Co., Ltd., trade name: Paindex # 4) in 60 parts by weight of water and adjusting the solution to 45 ° C. and pH 6.5, Experiment A-2 The non-reducing saccharide-forming enzyme prepared by the above method was added at a rate of 1 unit per g of reduced starch partial degradation product and reacted for 96 hours to produce a non-reducing saccharide having a trehalose structure at the end. Then, the enzyme was inactivated by heating at 100 ° C. for 10 minutes. This reaction solution is diluted to a concentration of about 20%, glucoamylase (manufactured by Nagase Seikagaku Co., Ltd., trade name Glucozyme) is added for 10 units per g of partially decomposed starch, reacted for 40 hours, and then heated, Was deactivated. This solution was decolorized with activated carbon, desalted with an ion exchange resin, and concentrated to a concentration of about 60% according to a conventional method. The sugar solution contained 29.5% trehalose per solid. This concentrated liquid was charged at 60 ° C. and SV 0.4 to a jacketed stainless steel column packed with a salt-type strongly acidic cation exchange resin (Sold by Organo Co., Ltd., trade name: CG6000, Na type). Minutes were collected. The high content liquid contained about 90% trehalose per solid. After concentrating this solution to a concentration of about 75%, it was placed in an auxiliary crystal can, and about 2% of a trehalose hydrous crystal was added as a seed crystal and slowly cooled to obtain a mass kit having a crystallization rate of about 45%. This mass kit is 150kg / cm from the nozzle on the drying tower.2Sprayed at high pressure. At the same time, hot air of 85 ° C. is blown from the top of the drying tower, the crystal powder is collected on a transfer wire mesh conveyor provided at the bottom, and hot air of 45 ° C. is sent from the bottom of the conveyor while the powder is dried. It was gradually moved out and removed. This crystal powder was packed in an aging tower and aged for 10 hours while sending warm air, and crystallization and drying were completed to obtain a water-containing trehalose crystal powder.
[0064]
[Experiment B-1 Preparation of maltosyl glucoside]
5 parts by weight of 98% pure maltopentaose (manufactured by Hayashibara Biochemical Laboratories Co., Ltd.) was dissolved in 10 parts by weight of water and adjusted to pH 7.0 and temperature of 40 ° C. The prepared non-reducing saccharide-forming enzyme was added to 2 units per maltopentaosegram. After reacting for 48 hours, the enzyme was inactivated by heating at 100 ° C. for 20 minutes. The solution contained about 88% maltotetraosyl glucoside per solid.
[0065]
This maltotetraosyl glucoside-containing solution is adjusted to pH 5.5 and a temperature of 40 ° C., and β-amylase (manufactured by Nagase Seikagaku Corporation, trade name # 1500) is added so as to be 20 units per gram of solid matter. Then, after reacting for 24 hours, the enzyme was inactivated by heating at 100 ° C. for 20 minutes. This liquid contained about 53% of maltosyl glucoside per solid, and additionally contained maltose and maltotriose.
[0066]
This solution was decolorized with activated carbon according to a conventional method, desalted with an ion exchange resin (H type and OH type), and concentrated to a solid concentration of about 50%. Subsequently, this concentrated solution was subjected to column chromatography using a salt-type strongly acidic cation exchange resin in accordance with the method of Experiment A-6, and a fraction containing a high content of maltosylglucoside was collected. This solution contained about 81% maltosyl glucoside per solid.
[0067]
Further, in order to increase the purity, sodium hydroxide was added to this solution to a concentration of 0.1 N, and the mixture was heated at 100 ° C. for 2 hours to decompose the reducing saccharide. This reaction solution was decolorized and desalted according to a conventional method, and concentrated to a solid concentration of about 50%. This solution contained about 94% maltosyl glucoside per solid. The collected maltosyl glucoside-rich solution is further subjected to preparative liquid chromatography (manufactured by YMC Co., Ltd., preparative column YMC-Pack R-355-15) using octadecyl silica gel as a carrier, and the purity of maltosyl glucoside is about A high content fraction of 99% or more was collected.
[0068]
This fraction was further purified according to a conventional method, concentrated to a concentration of 78%, placed in a beaker, and left in a cold room at 4 ° C., whereupon precipitation of crystals was observed. The crystals were collected by centrifugation and washed with a small amount of water to obtain hydrous crystals having a purity of 99.9%. The product was dried under reduced pressure at 100 ° C. overnight to obtain anhydrous crystals.
[0069]
When the physicochemical properties of these crystals were examined, they were as follows.
(1) Elemental analysis (as anhydride)
Hydrous crystal C = 42.4% H = 6.8%
Anhydrous crystal C = 42.6% H = 6.7%
Theoretical value C = 42.86% H = 6.39%
(2) Mass spectrometry (as anhydride)
MW = 504 (molecular formula C18H32016)
(3) Moisture
Measured by Karl Fischer method
Water-containing crystals 9.9% (1 mol of maltosylglucoside and 3 mol of water)
Anhydrous crystals 0.3%
(4) Melting point
When water-containing crystals or anhydrous crystals of maltosylglucoside were placed in a melting point measuring device and the melting point was observed at a heating rate of 1 ° C. per minute, all the crystals melted at 180 ° C. This does not necessarily mean that the melting points of both crystals are the same. For example, in the case of a water-containing crystal, the water-containing crystal is changed from the water-containing crystal to the anhydrous crystal without any change in appearance during heating and heating. It is considered that the melting phenomenon of the anhydrous crystals is observed.
(5) Specific rotation (as anhydride)
Both hydrous and anhydrous crystals
[Α]D 20 + 207.9 ° (c = 5.0, H2O)
(6) UV absorption spectrum
Neither hydrous crystals nor anhydrous crystals show characteristic absorption when measured in aqueous solution.
(7) Infrared absorption spectrum
A transparent tablet was prepared by stirring and mixing 2 mg of powder of hydrous crystal or anhydrous crystal with 200 mg of dry KBr, and the infrared absorption spectrum was measured. The results showed almost the same pattern for both hydrous crystals and anhydrous crystals. FIG. 5 shows the results of the water-containing crystal.
(8) Solubility (as anhydride)
About 163 g of both hydrous crystals and anhydrous crystals are dissolved in 100 ml of water at 25 ° C.
(9) Sweetness (as anhydride)
Since the sweetness of the 25% aqueous solution of maltosylglucoside is almost the same as that of the 10% aqueous solution of sucrose, it is about 40% sweetness of sucrose. The quality of sweetness is extremely excellent.
(10) Color reaction
Both hydrous and anhydrous crystals are green in anthrone-sulfuric acid reaction, and Ferring's liquid reduction reaction and iodine reaction are negative.
(11) Structure (as anhydride)
(A) When hydrolyzed with 1N-sulfuric acid, only D-glucose is produced.
(B) By the action of glucoamylase, 1 mol of glucose and 1 mol of trehalose were produced.
(C) Carbon nuclear magnetic resonance analysis (13The results of (C-NMR) are shown in FIG.
Klaus Bock et al., “Advanced in Carbohydrate Chemistry and Biochemistry”, Vol. 42, pp. 193-225 (1984) From the chemical shifts of the standard substance, α-D-glucopyranose, α, α-trehalose and maltooligosaccharide, and this substance is O-α-D-glucopyranosyl- (1 → 4) -α -D-glucopyranosyl It is judged to have the structure of α-D-glucopyranoside, that is, maltosylglucoside.
(12) Powder X-ray diffraction
F. H. Stodola et al., “Journal of the American Chemical Society”, Vol. 78, pages 2514-2518 (1956). The powder X-ray diffraction pattern using CuKα rays of crystalline maltosyl glucoside was measured according to the method reported in the above. The result of the water-containing crystal is shown in FIG. 7, and the result of the anhydrous crystal is shown in FIG. As is apparent from the results of FIGS. 7 and 8, the water-containing crystal has 7.9 °, 13.2 °, 17.2 ° and 22.6 ° as main diffraction angles (2θ) in the powder X-ray diffraction method. In addition, anhydrous crystals have 7.7 °, 13.5 °, 17.6 ° and 23.6 °.
[0070]
From the above facts, the crystal of the present invention is judged to be a maltosylglucoside crystal that has never been known.
[0071]
[Experiment B-2 Hygroscopicity and its effect on crystalline maltosyl glucoside and amorphous maltosyl glucoside]
About 1 g each of water-containing crystalline maltosyl glucoside, anhydrous crystalline maltosyl glucoside and amorphous maltosyl glucoside in a powder state are taken in a polyethylene container and left in a high humidity atmosphere with a relative humidity of 90.1%. Their water content was measured and the change in the state of the powder was observed. As the sample, the water-containing crystal and the anhydrous crystal were prepared by the method of Experiment B-1, and the amorphous was prepared by dissolving the water-containing crystal with deionized water and vacuum drying. The results are summarized in Table 5.
[0072]
[Table 5]
[0073]
As is apparent from the results in Table 5, it was found that amorphous maltosyl glucoside absorbs moisture significantly and solidifies, and easily loses fluidity. On the other hand, it has been found that the water-containing crystal has a low moisture absorption, retains fluidity, and is easy to handle. In addition, although anhydrous crystals absorb moisture, they retain fluidity with no change in appearance, and thus are considered to be stable by changing from anhydrous crystals to water-containing crystals.
[0074]
[Experiment B-3 Acute toxicity test]
Using mice, the acute toxicity test was conducted by orally administering the water-containing crystals and anhydrous crystals of maltosylglucoside prepared by the method of Experiment B-1. As a result, these crystalline maltosyl glucosides are low-toxic substances, and no deaths were observed even at the maximum dose that could be administered. Therefore, although the exact value cannot be said, the LD50 value was 50 g / kg or more in any case.
[0075]
Hereinafter, the production method of the crystalline maltosyl glucoside of the present invention is shown in Example A, and its use is shown in Example B.
[0076]
Example A-1
Prepared by the method of Experiment A-2 after heating and dissolving 50 parts by weight of 95% pure maltopentaose (manufactured by Hayashibara Biochemical Laboratories Co., Ltd.) in 200 parts by weight of water and adjusting the pH to 7.0 and the temperature to 40 ° C. The non-reducing saccharide-forming enzyme was added to 5 units per maltopentaosegram and allowed to react for 24 hours. This reaction solution was heated to inactivate the enzyme. This solution contained about 83% maltotetraosyl glucoside per solid. This liquid was concentrated to a solid concentration of about 50% and left in a cold room to precipitate maltotetraosyl glucoside crystals, which were filtered to collect crystalline maltotetraosyl glucoside.
[0077]
10 parts by weight of this crystalline maltotetraosyl glucoside is dissolved by heating in 100 parts by weight of water, adjusted to pH 5.5 and temperature of 50 ° C., and β-amylase (manufactured by Nagase Seikagaku Corporation, trade name # 1500) is solid. Added to 20 units per gram. After reacting for 24 hours, the enzyme was inactivated by heating at 100 ° C. for 20 minutes. This liquid contained about 58% maltosylglucoside per solid, and contained maltose and a small amount of maltotriose.
[0078]
This solution was decolorized with activated carbon according to a conventional method, desalted with an ion exchange resin (H type and OH type), and concentrated to a solid concentration of about 50%. This concentrated liquid was placed in a jacketed stainless steel column (5.4 cm × 4 m connected in series of 4) filled with a salt type strongly acidic cation exchange resin (manufactured by Organo Corporation, trade name: XT-1016, Na type). The fraction was charged at 40 ° C. and SV 0.4, and then eluted with warm water at 60 ° C. to collect a fraction containing a high content of maltosylglucoside. This solution contained about 92% maltosyl glucoside per solid.
[0079]
This solution is decolorized with activated carbon, deionized with ion exchange resin (H type and OH type), and concentrated to a solid concentration of about 80% according to a conventional method. Silglucoside was added as a seed crystal at 2%, and assisted crystallization was carried out with slow stirring while slowly cooling. The obtained mass kit was honeyed with a basket-type centrifuge, washed with a small amount of water, and then dried. Water-containing crystalline maltosyl glucoside having a purity of 99.4% was collected.
[0080]
This product does not substantially exhibit hygroscopicity, is easy to handle, and is used as a sweetener, taste improver, quality improver, stabilizer, excipient, etc. for foods, drinks, cosmetics, pharmaceuticals, molded products, etc. It can be advantageously used in various compositions.
[0081]
Example A-2
Potato starch having a concentration of about 20% containing 0.1% calcium carbonate was adjusted to pH 6.0, and then α-amylase (manufactured by Novo Nordisk Industries, trade name Termamil 60 L) was added at 0.3 per gram starch solids. % And heated to 95 to 100 ° C. to gelatinize and liquefy the starch, and then heat deactivate the enzyme to obtain a liquefied liquid of DE19.5.
[0082]
This solution was adjusted to pH 6.2,
[0083]
This was purified and concentrated in the same manner as in Example A-1, and subjected to column chromatography using a salt-type strongly acidic cation exchange resin to collect a fraction containing high maltosylglucoside. This solution contained about 89% maltosyl glucoside per solid.
[0084]
This solution is decolorized with activated carbon according to a conventional method, desalted with ion exchange resins (H type and OH type), concentrated to a solid concentration of about 85%, and crystalline maltosyl glucoside as a seed crystal. % Was added and crystallization was carried out while slowly cooling and slowly stirring. The obtained mass kit was honeyed with a basket-type centrifuge, washed with a small amount of water, and then dried. Water-containing crystalline maltosylglucoside having a purity of 98.1% was collected.
[0085]
This product does not substantially exhibit hygroscopicity, is easy to handle, and is used as a sweetener, taste improver, quality improver, stabilizer, excipient, etc. for foods, drinks, cosmetics, pharmaceuticals, molded products, etc. It can be advantageously used in various compositions.
[0086]
Example A-3
Using starch partial decomposition product (manufactured by Matsutani Chemical Industry Co., Ltd., trade name: Paindex # 4), adjusting the concentration to 20%, pH 5.5, temperature 45 ° C, adding 500 units of isoamylase per gram of starch partial decomposition product For 24 hours to decompose starch-derived α-1,6 bonds. The reaction solution was heated to 100 ° C. and kept for 10 minutes, and then cooled to 40 ° C. to adjust the pH to 6.5. To this, 5 units of non-reducing saccharide-forming enzyme prepared by the method of Experiment A-2 was added per gram of solid matter, reacted for 48 hours, the reaction solution was heated to 100 ° C., kept for 10 minutes, and then cooled. . After adjusting the temperature to 50 ° C., add β-amylase to 50 units per gram of solids and α-amylase to 10 units, react for 24 hours, and then heat at 100 ° C. for 20 minutes to lose the enzyme. I made it live. This liquid contained about 24% maltosylglucoside per solid.
[0087]
This was purified and concentrated in the same manner as in Example A-1, and subjected to column chromatography using a salt-type strongly acidic cation exchange resin to collect a fraction containing a high content of maltosylglucoside. This solution contained about 91% maltosyl glucoside per solid.
[0088]
This solution is decolorized with activated carbon according to conventional methods, desalted with ion exchange resins (H type and OH type), concentrated to a solid concentration of about 85%, and crystalline maltosyl glucoside is used as a seed crystal. 3% was added, and crystallization was carried out with slow stirring to obtain a mass kit having a crystallization rate of about 45%.
[0089]
This mass kit is 150kg / cm from the nozzle on the drying tower.2Sprayed at high pressure. At the same time, hot air at 85 ° C. is blown from the top of the drying tower, the crystal powder is collected on a transfer wire mesh conveyor provided at the bottom of the drying tower, and hot powder at 45 ° C. is sent from below the conveyor while Gradually moved out of the drying tower. This powder crystal was packed in an aging tower and aged for 10 hours while sending warm air to complete crystallization and drying to obtain a hydrous crystalline maltosylglucoside-containing powder.
[0090]
This product does not substantially exhibit hygroscopicity, is easy to handle, and is used as a sweetener, taste improver, quality improver, stabilizer, excipient, etc. It can be advantageously used in various compositions.
[0091]
Example A-4
Malt obtained by allowing isoamylase, non-reducing saccharide-forming enzyme, then β-amylase and α-amylase to act on the partially degraded starch in the same manner as in Example A-3, followed by separation and purification The liquid containing high sylglucoside was concentrated to a concentration of about 80%. This concentrated solution was taken in an auxiliary crystal can, 2% of crystalline maltosyl glucoside was added as a seed crystal, and the auxiliary crystal was agitated while slowly stirring, and then taken out into a vat to prepare a block. The block was allowed to stand at about 25 ° C. for 2 days and aged, and then pulverized with a cutting pulverizer, fluidized and classified to obtain hydrous crystalline maltosylglucoside-containing powder.
[0092]
This product does not substantially exhibit hygroscopicity, is easy to handle, and is used as a sweetener, taste improver, quality improver, stabilizer, excipient, etc. It can be advantageously used in various compositions.
[0093]
Example A-5
The hydrous crystalline maltosyl glucoside obtained by the method of Example A-1 was dried under reduced pressure at 100 ° C. overnight to obtain anhydrous crystalline maltosyl glucoside having a water content of about 0.2%.
[0094]
This product absorbs moisture when left indoors and easily returns to water-containing crystalline maltosylglucoside with a water content of about 10% for stabilization. The anhydrous crystalline maltosyl glucoside can be advantageously used as a seed crystal, and can also be advantageously used as a hygroscopic agent, a dehydrating agent, a chemical raw material, or the like. Furthermore, it can be advantageously used in various compositions such as foods and drinks, cosmetics, pharmaceuticals, and molded products.
[0095]
Example A-6
1 part by weight of trehalose and 1 part by weight of a partially decomposed starch (manufactured by Matsutani Chemical Industry Co., Ltd., trade name: Paindex # 4) are heated and dissolved in 3 parts by weight of water, adjusted to a temperature of 65 ° C. and pH 6.0. Cyclomaltodextrin glucanotransferase derived from Bacillus stearothermophilus (manufactured by Hayashibara Biochemical Laboratories Co., Ltd.) was added at 10 units per gram of the partially decomposed starch and reacted for 24 hours, and then the enzyme was inactivated by heating. . Next, the temperature was adjusted to 55 ° C., and pullulanase (manufactured by Hayashibara Biochemical Laboratories Co., Ltd.) and β-amylase were added to each unit of 25 units and 50 units per gram of the partially decomposed starch and reacted for 24 hours. Was inactivated by heating. This reaction solution contained about 25% maltosylglucoside per solid.
[0096]
This was purified in the same manner as in Example A-1, and subjected to column chromatography using a salt-type strongly acidic cation exchange resin to obtain a fraction containing a high content of maltosylglucoside, which was decolorized, desalted, concentrated, and promoted. The block was made by taking it out into a bat. This block was cut, dried, and classified to obtain a hydrous crystalline maltosylglucoside-containing powder with a yield of about 17% per raw material.
[0097]
This product does not substantially exhibit hygroscopicity and is easy to handle, and as a sweetener, taste improver, quality improver, stabilizer, excipient, etc., food, drinks, cosmetics, pharmaceuticals, molded products, etc. It can be advantageously used in various compositions.
[0098]
Example B-1 Sweetener
To 1 part by weight of the high-purity water-containing crystalline maltosyl glucoside obtained by the method of Example A-1, 0.05 part by weight of α-glycosyl stevioside (sold by Toyo Seika Co., Ltd., trade name: αG sweet) is uniformly mixed to obtain granules. A granular sweetener was obtained through a molding machine. This product has excellent sweetness quality, has about twice the sweetness of sucrose, and the calorie per sweetness is about 1/2 that of sucrose. This sweetener is suitable as a low-calorie sweetener for sweetening low-calorie foods and drinks for obese, diabetics and the like who restrict caloric intake. Further, the present sweetener is suitable for sweetening foods and the like that suppress dental caries because it produces less acid by caries-inducing bacteria and produces less insoluble glucan.
[0099]
[Example B-2 Hard Candy]
30 parts by weight of water-containing crystalline maltosylglucoside-containing powder obtained by the method of Example A-3 was heated and mixed with 100 parts by weight of 55% sucrose solution, and then heated and concentrated under reduced pressure until the water content was less than 2%. 1 part by weight of citric acid and an appropriate amount of lemon flavor and colorant were mixed and molded according to a conventional method to obtain a product. This product is a high quality hard candy that is crisp, tastes good and does not cause sucrose crystallization.
[0100]
[Example B-3 Strawberry jam]
Stew 150 parts by weight raw strawberries, 60 parts by weight sucrose, 20 parts by weight maltose, 40 parts by weight hydrous crystalline maltosylglucoside powder obtained by the method of Example A-4, 5 parts by weight pectin and 1 part by weight citric acid. Bottled to get the product. This product is a jam with good flavor and color.
[0101]
[Example B-4 Cream wafer]
2,000 parts by weight of high-purity anhydrous crystalline maltosyl glucoside obtained by the method of Example A-5, 1,000 parts by weight of shortening, 1 part by weight of lecithin, 1 part by weight of lemon oil, and 1 part by weight of vanilla oil The cream obtained by mixing was heated and kept at 40 to 45 ° C., and sandwiched between wafers to produce a cream wafer. This product has a smooth cream melt and good flavor.
[0102]
[Example B-5 Sweetened condensed milk]
5 parts by weight of the high-purity water-containing crystalline maltosylglucoside obtained by the method of Example A-2 is dissolved in 100 parts by weight of raw milk, sterilized by heating with a plate heater, then concentrated to a concentration of about 70%, and canned in aseptic conditions. And got the product. This product has a mild sweet taste and good flavor, and can be advantageously used for seasoning infant foods, fruits, coffee, cocoa, tea, and the like.
[0103]
[Example B-6 Lactic acid beverage]
10 parts by weight of skim milk was sterilized by heating at 80 ° C. for 20 minutes, cooled to 40 ° C., 0.3 parts by weight of a starter was added thereto, and fermented at about 37 ° C. for 10 hours. Next, after homogenizing this, 5 parts by weight of high-purity water-containing crystalline maltosylglucoside obtained by the method of Example A-2 and 2 parts by weight of isomerized sugar syrup were added and sterilized by maintaining at 70 ° C. This was cooled, an appropriate amount of fragrance was added, and bottled to obtain a product. This product is a high quality lactic acid beverage whose flavor and sweetness are in good harmony with acidity.
[0104]
[Example B-7 powdered juice]
For 33 parts by weight of orange juice powder produced by spray drying, 50 parts by weight of high-purity hydrous crystal maltosylglucoside obtained by the method of Example A-2, 10 parts by weight of sucrose, 0.65 parts by weight of anhydrous citric acid, apple 0.1 part by weight of acid, 0.1 part by weight of L-ascorbic acid, 0.1 part by weight of sodium citrate, 0.5 part by weight of pullulan, and appropriate amount of powdered fragrance are mixed and stirred well, pulverized into a fine powder. Charged to fluidized bed granulator, exhaust air temperature set to 40 ° C, sprayed with high concentration maltosylglucoside concentrate obtained by the method of Example A-2 as binder, granulated for 30 minutes, weighed and packaged And got the product. This product is a powdered juice with a fruit juice content of about 30%. In addition, this product had no off-flavors and off-flavors, and did not cause moisture absorption and consolidation, and was stable for a long time.
[0105]
[Example B-8 Chocolate]
After mixing 40 parts by weight of cocoa paste, 10 parts by weight of cocoa butter, 20 parts by weight of sucrose, and 30 parts by weight of high-purity water-containing crystal maltosyl glucoside obtained by the method of Example A-1, the particle size is reduced by passing through a refiner Put in a conche and knead at 50 ° C for 2 days. During this period, 0.5 parts by weight of lecithin was added and sufficiently mixed and dispersed. Next, the temperature was adjusted to 31 ° C. with a temperature controller, poured into a mold just before the butter solidified, drained with a vibrator, and passed through a 10 ° C. cooling tunnel for 20 minutes to solidify. This was punched and packaged to obtain a product. This product has no hygroscopicity, good color and gloss, good internal structure, melts smoothly in the mouth, and has an elegant sweetness and mellow flavor.
[0106]
[Example B-9 Chewing gum]
3 parts by weight of gum base is heated and melted to a degree of softening, and 4 parts by weight of anhydrous crystalline maltitol (registered trademark Mabito, Hayashibara Shoji Co., Ltd.) and the high purity water-containing crystalline maltosyl glucoside obtained by the method of
[0107]
[Example B-10 Custard cream]
100 parts by weight of corn starch, 100 parts by weight of the hydrous crystalline maltosylglucoside-containing powder obtained by the method of Example A-3, 80 parts by weight of maltose (registered trademark Sanmalto, Hayashibara Shoji Co., Ltd.), 20 parts by weight of sucrose and 1 part by weight of sodium chloride Mix well, add 280 parts by weight of chicken egg, stir in, gradually add 1,000 parts by weight of boiled milk, and continue to stir over heat, until the corn starch is completely gelatinized and the whole When it became translucent, the fire was turned off, cooled, added with an appropriate amount of vanilla flavor, weighed, filled, and packaged to obtain a product. This product has a smooth luster, mild sweetness and deliciousness.
[0108]
Example B-11 Uiro Element
Rice bran was produced by uniformly mixing 90 parts by weight of rice flour with 20 parts by weight of corn starch, 120 parts by weight of hydrous crystalline maltosylglucoside-containing powder obtained by the method of Example A-6, and 4 parts by weight of pullulan. Ui-no-Moto, an appropriate amount of Matcha and water were kneaded, and the mixture was placed in a container and steamed for 60 minutes to produce Matcha Uiro. This product has good shine, mouthfeel, and good flavor. Moreover, the aging of starch is suppressed and the shelf life is good.
[0109]
[Example B-12 Instant Corn Potage Soup]
30 parts by weight of α-ized corn powder, 5 parts by weight of α-ized wheat flour, 4 parts by weight of α-ized potato starch, 12 parts by weight of α-ized waxy corn starch, hydrous crystal maltosyl glucoside obtained by the method of Example A-3 After containing 8 parts by weight of powder, 5 parts by weight of sodium glutamate, 8.5 parts by weight of sodium chloride, 7 parts by weight of skim milk powder and 0.5 parts by weight of onion powder, they were mixed well, and then sorbitan fatty acid ester 0.5 What was heated and melted by weight and 9 parts by weight of vegetable hardened oil was added and mixed. Further, 10 parts by weight of lactose was added and mixed, and this was fluidized bed granulator as in Example B-7. The mixture was sprayed with a small amount of water, granulated, dried with hot air at 70 ° C., and sieved to produce instant corn potage soup. If hot water is poured into this product, it will dissolve and disperse easily, resulting in a flavorful soup.
[0110]
[Example B-13 Bettakarazuke-no-moto]
4 parts by weight of water-containing crystalline maltosylglucoside-containing powder obtained by the method of Example A-4, 0.05 parts by weight of licorice preparation, 0.008 parts by weight of malic acid, 0.07 parts by weight of sodium glutamate, 0. When 03 parts by weight and 0.2 parts by weight of pullulan were uniformly mixed, a pickle was prepared. According to a conventional method, 30 kg of radish was submerged with sodium chloride and then soaked with sucrose, and then soaked in a seasoning solution prepared with 4 kg of the main marinade. This product was good in color, gloss and aroma, had moderate sweetness, and was crisp. In addition, this product was resistant to rancidity and was stable for a long time.
[0111]
[Example B-14 Tube feeding agent]
20 parts by weight of high-purity water-containing crystalline maltosyl glucoside obtained by the method of Example A-1, 1.1 parts by weight of glycine, 1 part by weight of sodium glutamate, 0.4 parts by weight of calcium lactate, 0.1 parts by weight of magnesium carbonate, A formulation consisting of 0.01 parts by weight thiamine and 0.01 parts by weight riboflavin is prepared. Each 24 g of this blend was filled into a laminated aluminum parcel and heat sealed to obtain a product. This product is dissolved in about 33 to 500 ml of water to make a nutritional supplement, and administered to the nasal cavity, gastrointestinal tract, etc. by the tube method. This product can be advantageously used not only as a human but also as a parenteral nutritional supplement for livestock.
[0112]
[Example B-15 Tube feeding agent]
580 parts by weight of high-purity water-containing crystalline maltosyl glucoside obtained by the method of Example A-2, 190 parts by weight of dried egg yolk, 209 parts by weight of skim milk powder, 4.4 parts by weight of sodium chloride, 1.85 parts by weight of potassium chloride, sulfuric acid A formulation comprising 4 parts by weight of magnesium, 0.01 parts by weight of thiamine, 0.1 parts by weight of sodium ascorbate, 0.6 parts by weight of vitamin E acetate and 0.04 parts by weight of nicotinamide is prepared. Each 25 g of this blend was filled into a laminated aluminum package and heat sealed to obtain a product. This product is used by dissolving 1 bag in about 150 to 300 ml of water to give a nutritional supplement and administering it to the nasal cavity, esophagus, stomach, etc. by the tube method.
[0113]
[Example B-16 Plaster for treatment of trauma]
50 parts by weight of methanol in which 3 parts by weight of iodine was dissolved and mixed with 300 parts by weight of high-purity hydrous crystalline maltosylglucoside and 200 parts by weight of crystalline maltose obtained by the method of Example A-1, and further mixed with 200% pullulan aqueous solution 200 Part by weight was added and mixed to obtain a plaster for the treatment of trauma showing moderate extension and adhesion. This product shortens the healing period and heals the wound surface cleanly.
[0114]
[Example B-17 Interferon Solution]
Human natural interferon-γ preparation (manufactured by Hayashibara Biological Laboratories Co., Ltd., sold by Cosmo Bio Inc.) is applied to an immobilized anti-human interferon-γ antibody column according to a conventional method, and humans contained in the preparation High purity obtained by adsorbing natural interferon-γ, passing through and removing bovine serum albumin as a stabilizer, and then changing the pH to obtain human natural interferon-γ by the method of Example A-1. Elution was performed using physiological saline containing 7% of hydrous crystal maltosylglucoside. This solution is microfiltered, aseptically filled into vials, and 10 natural human interferon-γ per ml.FiveA liquid containing the unit was obtained. About 1 to 20 ml of adult is orally or parenterally administered per day, this product can be advantageously used for the treatment of viral diseases, allergic diseases, rheumatism, diabetes, malignant tumors and the like. In this product, maltosyl glucoside acts as a stabilizer and maintains its activity well even when left at 4 ° C. or 25 ° C. for 20 days.
[0115]
[Example B-18 Tsumore Necrosis Factor Solution]
Human natural type Tsumore Necrosis factor-α preparation (manufactured by Hayashibara Biochemical Laboratories Co., Ltd., sold by Cosmo Bio Inc.) is applied to an immobilized anti-Human Tsumore Necrosis factor-α antibody column according to a conventional method, Adsorbs human natural tsumoa necrosis factor-α contained in the preparation, and passes bovine serum albumin as a stabilizer.RNext, physiological saline containing 10% of high-purity water-containing crystalline maltosyl glucoside obtained by the method of Example A-1 by changing the pH and obtaining human natural type Tsumor necrosis factor-α by the method of Example A-1. And eluted. This solution is microfiltered, aseptically filled into vials, and human natural tsumoa necrosis factor-α is 10 per ml.4A liquid containing the unit was obtained. This product is administered orally or parenterally to about 1 to 20 ml of adult per day, and can be advantageously used for the treatment of viral diseases, allergic diseases, rheumatism, diabetes, malignant tumors and the like. In this product, maltosyl glucoside acts as a stabilizer and maintains its activity well even after standing at 4 ° C or 25 ° C for 20 minutes.
[0116]
[Example B-19 interferon tablet]
Human natural interferon-α preparation (manufactured by Hayashibara Biochemical Laboratories Co., Ltd., Cosmo Bio Co., Ltd.) is applied to an immobilized anti-human interferon-α antibody column according to a conventional method, and humans contained in the preparation High purity water-containing water obtained by adsorbing natural interferon-α, passing through and removing bovine serum albumin as a stabilizer, and then changing the pH to obtain human natural interferon-α by the method of Example A-1. Elution was performed using physiological saline containing 5% of crystalline maltosyl glucoside. This solution is finely filtered, added to about 20 times the amount of anhydrous crystalline maltose powder (Hayashibara Shoji Co., Ltd., trade name: Finetose T), dehydrated and powdered, and tableted with a tableting machine. A tablet containing about 150 units of human natural interferon-α per (about 200 mg) was obtained. This product can be used advantageously as a sublingual tablet for the treatment of viral diseases, allergic diseases, rheumatism, diabetes, malignant tumors, etc. In particular, it can be advantageously used as a therapeutic agent for AIDS, hepatitis, etc., whose number of patients is rapidly increasing in recent years. In this product, maltose acts as a stabilizer together with maltosyl glucoside and maintains its activity well for a long time even when left at room temperature.
[0117]
[Example B-20 Dragee]
A core tablet of 150 mg in weight is used as a core, and 45 parts by weight of high-purity water-containing crystalline maltosylglucoside obtained by the method of Example A-2, 2 parts by weight of pullulan (average molecular weight 200,000), 30 parts by weight of water, talc Using an undercoat liquid consisting of 25 parts by weight and 3 parts by weight of titanium oxide, sugar coating is carried out until the tablet weight reaches about 230 mg, then 65 parts by weight of the same water-containing crystalline maltosylglucoside-containing powder, 1 part by weight of pullulan and 34 parts by weight of water The sugar-coated tablets were coated with a top part liquid and further polished with a wax liquid to obtain a sugar-coated tablet with an excellent glossy appearance. This product not only has excellent workability when applied to sugar, but also has excellent impact resistance and maintains high quality for a long time.
[0118]
[Example B-21 Latex]
0.5 parts by weight of polyoxyethylene behenyl ether, 1 part by weight of polyoxyethylene sorbitol tetraoleate, 1 part by weight of glyceryl monostearate, 0.5 parts by weight of behenyl alcohol, 1 part by weight of avocado oil A high-purity hydrous crystal maltosyl glucoside obtained by the method of Example A-2, 3.5 parts by weight, α-
[0119]
[Example B-22 skin cream]
2 parts by weight of polyoxyethylene glycol monostearate, 5 parts by weight of glyceryl monostearate, 2 parts by weight of α-glycosyl rutin, 1 part by weight of liquid paraffin, 10 parts by weight of glyceryl trioctanoate, the method of
[0120]
[Example B-23 toothpaste]
45 parts by weight of dibasic calcium phosphate, 1.5 parts by weight of sodium lauryl sulfate, 25 parts by weight of glycerin, 0.5 parts by weight of polyoxyethylene sorbitan laurate, high-purity water-containing crystalline maltosyl glucoside obtained by the method of Example A-2 Toothpaste was obtained by mixing 15 parts by weight, 0.02 part by weight of saccharin and 0.05 part by weight of preservative with 13 parts by weight of water. This product has good gloss and detergency and is suitable as a toothpaste.
[0121]
[Example B-24 Fertilizer pile]
Compound fertilizer (N = 14%, P2OFive= 8%, K2O = 12%), pullulan, water-containing crystalline maltosylglucoside-containing powder obtained by the method of Example A-6, calcium sulfate and water after mixing sufficiently as 70, 5, 5, 15 and 5 respectively by weight A fertilizer pile was manufactured by heating to 80 ° C. with an extruder (L / D = 20, compression ratio = 1.8, die diameter = 30 mm). This product does not require a fertilizer container, is easy to handle, has strength suitable for full-layer fertilization, and can adjust the elution rate of fertilizer components by changing the blending ratio. If necessary, this fertilizer pile can be easily mixed with plant hormones, agricultural chemicals, soil conditioners and the like.
[0122]
【The invention's effect】
As is clear from the above, the crystalline maltosyl glucoside of the present invention is a substance that is substantially non-hygroscopic or hardly hygroscopic, has good fluidity, is easy to handle, is easily dissolved in water, and has an appropriate viscosity. And has a good sweetness. In addition, crystalline maltosyl glucoside is chemically stable and has the property of stabilizing amino acids and oligopeptides that are prone to browning reactions, as well as active ingredients and physiologically active substances that easily lose their activity. . In addition, it has properties such as osmotic pressure controllability, activation, irradiability, moisture retention, prevention of crystallization of other sugars, difficulty of fermenting, and anti-aging of starch. These various properties can be advantageously used in the production of various compositions such as foods and drinks, cosmetics, pharmaceuticals, and molded products.
[0123]
Therefore, the establishment of the crystalline maltosyl glucoside of the present invention, its production method, and its use has great industrial significance in the fields of food and drink, cosmetics, and pharmaceuticals.
[Brief description of the drawings]
FIG. 1 is a graph showing the effect of temperature on the activity of a non-reducing saccharide-forming enzyme derived from Rhizobium species M-11.
FIG. 2 is a graph showing the influence of pH on the activity of a non-reducing saccharide-forming enzyme derived from Rhizobium species M-11.
FIG. 3 is a graph showing the temperature stability of a non-reducing saccharide-forming enzyme derived from Rhizobium species M-11.
FIG. 4 is a graph showing the pH stability of a non-reducing saccharide-forming enzyme derived from Rhizobium species M-11.
FIG. 5 is an infrared absorption spectrum of hydrous crystal maltosyl glucoside.
FIG. 6 shows the results of carbon nuclear magnetic resonance analysis of maltosyl glucoside.
FIG. 7 shows a powder X-ray diffraction pattern of hydrous crystal maltosyl glucoside.
FIG. 8 is a diagram showing a powder X-ray diffraction pattern of anhydrous crystalline maltosyl glucoside.
Claims (8)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP06526195A JP3963491B2 (en) | 1994-03-01 | 1995-03-01 | Crystalline maltosyl glucoside, its production method and use |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5436994 | 1994-03-01 | ||
| JP6-54369 | 1994-03-01 | ||
| JP06526195A JP3963491B2 (en) | 1994-03-01 | 1995-03-01 | Crystalline maltosyl glucoside, its production method and use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH07291986A JPH07291986A (en) | 1995-11-07 |
| JP3963491B2 true JP3963491B2 (en) | 2007-08-22 |
Family
ID=26395126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP06526195A Expired - Lifetime JP3963491B2 (en) | 1994-03-01 | 1995-03-01 | Crystalline maltosyl glucoside, its production method and use |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3963491B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3970510A4 (en) * | 2019-05-13 | 2022-12-14 | Showa Sangyo Co., Ltd. | MODIFIER, MODIFIER COMPOSITION COMPRISING SUCH MODIFIER, FOOD AND BEVERAGE, MEDICINE, COSMETIC PRODUCT, INDUSTRIAL PRODUCT, FOOD, MEDIUM OR FERTILIZER USING THEM, AND METHOD FOR MODIFYING SUCH PRODUCTS |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001090338A1 (en) * | 2000-05-22 | 2001-11-29 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | α-ISOMALTOSYLTRANSFERASE, PROCESS FOR PRODUCING THE SAME AND USE THEREOF |
| JP4982716B2 (en) * | 2001-03-05 | 2012-07-25 | 株式会社林原 | Saccharide mixture, production method and use thereof |
| JPWO2004060077A1 (en) * | 2002-12-27 | 2006-05-11 | 株式会社林原生物化学研究所 | Method for reducing unpleasant taste and / or unpleasant odor |
| KR101217382B1 (en) * | 2003-02-13 | 2012-12-31 | 가부시끼가이샤 하야시바라 세이부쓰 가가꾸 겐꾸조 | EXTERNAL DERMATOLOGICAL FORMULATION COMPRISING SACCHARIDE DERIVATIVE OF α,α-TREHALOSE |
| WO2004076602A1 (en) * | 2003-02-27 | 2004-09-10 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Method of preventing lipids constituting lipid membrane from degradation and use thereof |
| CN1764388B (en) * | 2003-03-26 | 2010-05-05 | 株式会社林原生物化学研究所 | Powdering method and powdering base of non-sugar ingredients |
-
1995
- 1995-03-01 JP JP06526195A patent/JP3963491B2/en not_active Expired - Lifetime
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3970510A4 (en) * | 2019-05-13 | 2022-12-14 | Showa Sangyo Co., Ltd. | MODIFIER, MODIFIER COMPOSITION COMPRISING SUCH MODIFIER, FOOD AND BEVERAGE, MEDICINE, COSMETIC PRODUCT, INDUSTRIAL PRODUCT, FOOD, MEDIUM OR FERTILIZER USING THEM, AND METHOD FOR MODIFYING SUCH PRODUCTS |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH07291986A (en) | 1995-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3182679B2 (en) | Non-reducing oligosaccharides, their production and use | |
| KR100394149B1 (en) | Trehalose and its production and use | |
| JP3559585B2 (en) | Trehalose-releasing enzyme, its production method and use | |
| JP2896598B2 (en) | Lactoneotrehalose, its production method and use | |
| JP3633648B2 (en) | Maltose / trehalose converting enzyme, its production method and use | |
| JP3557235B2 (en) | Non-reducing carbohydrate-forming enzyme, its production method and use | |
| JP3793590B2 (en) | Non-reducing saccharides, production method and use thereof | |
| JP3557277B2 (en) | Thermostable trehalose releasing enzyme, its production method and use | |
| JP3082094B2 (en) | Method for producing neotrehalose and its use | |
| KR100362689B1 (en) | Reduced reducing sugar composition, its preparation method and use | |
| KR19980032612A (en) | Trehalose-containing syrup | |
| JP3557287B2 (en) | Thermostable non-reducing saccharide-forming enzyme, its production method and use | |
| JP3662972B2 (en) | Non-reducing saccharides, production method and use thereof | |
| JP4070250B2 (en) | Carbohydrate with reduced reducibility, its production method and use | |
| KR100350844B1 (en) | Non-reducing oligosaccharides with neotrehalose structure, preparation method and uses | |
| JP3616166B2 (en) | Trehalose and its production method and use | |
| JP3963491B2 (en) | Crystalline maltosyl glucoside, its production method and use | |
| KR100356840B1 (en) | Crystalline maltosyl glucoside, its preparation and shaped bodies containing the same | |
| KR100381889B1 (en) | Crystalline maltosyl glucoside, its preparation and cosmetics containing the same | |
| JP3936752B2 (en) | Crystalline maltotetraosyl glucoside, its production method and use | |
| JPH09224665A (en) | Beta-fructofuranosidase, production and use thereof | |
| JP2009269921A (en) | Trehalose-releasing enzyme and production method and application thereof | |
| US5908767A (en) | Non-reducing saccharide and its production and use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040601 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040802 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20040803 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070313 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070412 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20070515 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20070522 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130601 Year of fee payment: 6 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |